Nothing Special   »   [go: up one dir, main page]

WO2003054523A2 - Sensor and method for measuring the areal density of magnetic nanoparticles on a micro-array - Google Patents

Sensor and method for measuring the areal density of magnetic nanoparticles on a micro-array Download PDF

Info

Publication number
WO2003054523A2
WO2003054523A2 PCT/IB2002/005567 IB0205567W WO03054523A2 WO 2003054523 A2 WO2003054523 A2 WO 2003054523A2 IB 0205567 W IB0205567 W IB 0205567W WO 03054523 A2 WO03054523 A2 WO 03054523A2
Authority
WO
WIPO (PCT)
Prior art keywords
magnetoresistive
sensor device
magnetic
magnetoresistive sensor
nanoparticles
Prior art date
Application number
PCT/IB2002/005567
Other languages
French (fr)
Other versions
WO2003054523A3 (en
Inventor
Reinder Coehoorn
Menno W. J. Prins
Original Assignee
Koninklijke Philips Electronics N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koninklijke Philips Electronics N.V. filed Critical Koninklijke Philips Electronics N.V.
Priority to JP2003555187A priority Critical patent/JP2005513475A/en
Priority to KR10-2004-7009884A priority patent/KR20040068968A/en
Priority to DE60211555T priority patent/DE60211555T2/en
Priority to EP02790607A priority patent/EP1456658B1/en
Priority to US10/498,958 priority patent/US7048890B2/en
Priority to AU2002366904A priority patent/AU2002366904A1/en
Publication of WO2003054523A2 publication Critical patent/WO2003054523A2/en
Publication of WO2003054523A3 publication Critical patent/WO2003054523A3/en
Priority to US11/338,022 priority patent/US20060128035A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01RMEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00Arrangements or instruments for measuring magnetic variables
    • G01R33/12Measuring magnetic properties of articles or specimens of solids or fluids
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y25/00Nanomagnetism, e.g. magnetoimpedance, anisotropic magnetoresistance, giant magnetoresistance or tunneling magnetoresistance
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • C12Q1/6825Nucleic acid detection involving sensors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/06Investigating concentration of particle suspensions
    • G01N15/0656Investigating concentration of particle suspensions using electric, e.g. electrostatic methods or magnetic methods
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/72Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating magnetic variables
    • G01N27/74Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating magnetic variables of fluids
    • G01N27/745Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating magnetic variables of fluids for detecting magnetic beads used in biochemical assays
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/493Physical analysis of biological material of liquid biological material urine
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326Magnetic particles
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54373Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • G01N33/5438Electrodes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01RMEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00Arrangements or instruments for measuring magnetic variables
    • G01R33/02Measuring direction or magnitude of magnetic fields or magnetic flux
    • G01R33/06Measuring direction or magnitude of magnetic fields or magnetic flux using galvano-magnetic devices
    • G01R33/09Magnetoresistive devices
    • G01R33/093Magnetoresistive devices using multilayer structures, e.g. giant magnetoresistance sensors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01RMEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00Arrangements or instruments for measuring magnetic variables
    • G01R33/02Measuring direction or magnitude of magnetic fields or magnetic flux
    • G01R33/06Measuring direction or magnitude of magnetic fields or magnetic flux using galvano-magnetic devices
    • G01R33/09Magnetoresistive devices
    • G01R33/096Magnetoresistive devices anisotropic magnetoresistance sensors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01RMEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00Arrangements or instruments for measuring magnetic variables
    • G01R33/12Measuring magnetic properties of articles or specimens of solids or fluids
    • G01R33/1269Measuring magnetic properties of articles or specimens of solids or fluids of molecules labeled with magnetic beads
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/143Magnetism, e.g. magnetic label
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/155Particles of a defined size, e.g. nanoparticles
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2446/00Magnetic particle immunoreagent carriers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10NELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10N50/00Galvanomagnetic devices
    • H10N50/10Magnetoresistive devices

Definitions

  • the present invention relates to a method and apparatus for sensing of randomly positioned nanometer-scale magnetic particles.
  • it relates to magnetic detection apparatus and a method for binding of biological molecules on a micro-array or biochip.
  • the introduction of micro-arrays or biochips is revolutionising the analysis of
  • DNA deoxyribonucleic acid
  • RNA ribonucleic acid
  • proteins proteins.
  • Applications are e.g. human genotyping (e.g. in hospitals or by individual doctors or nurses), bacteriological screening, biological and pharmacological research.
  • Biochips also called biosensor chips, biological microchips, gene-chips or DNA chips, consist in their simplest form of a substrate on which a large number of different probe molecules are attached, on well defined regions on the chip, to which molecules or molecule fragments that are to be analysed can bind if they are perfectly matched. For example, a fragment of a DNA molecule binds to one unique complementary DNA (c-DNA) molecular fragment. The occurrence of a binding reaction can be detected, e.g. by using fluorescent markers that are coupled to the molecules to be analysed. This provides the ability to analyse small amounts of a large number of different molecules or molecular fragments in parallel, in a short time.
  • One biochip can hold assays for 1000 or more different molecular fragments. It is expected that the usefulness of information that can become available from the use of biochips will increase rapidly during the coming decade, as a result of projects such as the Human Genome Project, and follow-up studies on the functions of genes and proteins.
  • CMS Clinical Micro Sensors
  • binding or hybridisation, occurs.
  • the system also contains DNA sequences, called signaling probes, with proprietary electronic labels attached to them. These signaling probes also bind to the target DNA sequence. Binding of the target sequence to both the capture probe and the signaling probe connects the electronic labels to the surface. Binding of a molecular fragment is detected by the occurrence of an AC current through an electrode on which the molecules are bound, when a slight AC voltage is applied between the electrode and the solution above the chip, because the labels release electrons, producing a characteristic signal that can be detected through the electrode. This indicates the presence of the target DNA. Within this concept, the signal is proportional to the absolute number of binding reactions that have taken place.
  • a second principle is a Bead Array Counter (BARC) biochip, as described in
  • free-floating magnetic streptavidin coated micro-beads 106 are added, after probe-sample DNA hybridization has taken place.
  • the beads bind to the sample DNA that has hybridized with probe DNA by the formation of a streptavidin-biotinyl bond. So if sample DNA 105 having sequences complementary to both probes 104 is present, the sample DNA 105 will attach the beads 106 to the sensors 101.
  • the beads 106 used have a diameter of the order of 1 ⁇ m. In the beads 106, nanometer scale magnetic particles are present (not represented in the drawing), which are superparamagnetic due to their small size.
  • Nanometer-sized particles are typically of iron oxide, and are dispersed in, layered onto, or coated with a polymer or silica matrix to form beads of about 1 ⁇ m in diameter.
  • Non-binding beads are taken away by making use of a small magnetic field in combination with a small field gradient or by rinsing with a buffer solution.
  • the presence of the binding beads on the biochip is then detected by magnetising the particles in a relatively small, known, external magnetic field that is directed perpendicular to the plane of the substrate.
  • the presence of particles is detected by making use of giant magnetoresistive (GMR) half Wheatstone bridge type sensors in the substrate, with a resistance versus applied field curve as shown in figure 2.
  • the half Wheatstone bridge consists of one sensitive part above which beads are present, and one reference part above which no beads are present.
  • the resistance versus field curve of the GMR material used is almost symmetric around zero field, as shown in Fig. 2, so that the sign of the field direction is not measured.
  • the resistance of the GMR material decreases by about a same amount in response to a positive or negative applied field. It can be seen from Fig. 2 that there is a certain hysteresis in the GMR material, which is particularly manifest close to zero field. Consequently, accurate detection of small magnetic fields is almost impossible.
  • the BARC biochipconcept works, but the results given in Fig. 9 of D.R. Baselt, "A biosensor based on magnetoresistance technology", Biosensors & Bioelectronics 13, 731-739 (1998) show a poor signal-to-noiseratio(SNR).
  • the main problem is that the large (1 ⁇ m scale) beads used diffuse slowly through the solution, so even after a relatively long time allowed for binding between the beads and the sample DNA only a relatively small number of beads will have bound to hybridized sample molecules, leading to a weak signal.
  • the beads have a certain distribution of their magnetic moment (at a given field), which negatively affects the signal-to-noise ratio when only one or a few beads are present per sensor.
  • the signal-to-noise ratio for measurement of a single bead could be enhanced by making use of smaller sensor surface areas.
  • the electronic circuitry that is required becomes very complex.
  • the slow Brownian motion of the large magnetic particles of about 1 ⁇ m means that it can take a long time before the magnetic particle reaches a binding site. Thus actual measurements take a long time.
  • Tondra et al. describe in "Model for detection of immobilized superparamagnetic nanosphere assay labels using giant magnetoresistive sensors", J. Vac. Sci. Technol. A 18(4), Jul/Aug 2000, pp.1125-1129, that a GMR sensor can detect a single paramagnetic bead of any size, as long as a certain conditions are met, one of which is that the sensor is about the same size as the bead. This condition is easily met at a bead radius of 500 nm. Reducing the bead radius to 100 nm is possible by overcoming technical difficulties in fabrication of GMR sensors.
  • Chemla et al. describe in the article "Ultrasensitive magnetic biosensor for homogeneous immunoassay", PNAS, December 19, 2000, vol. 97, no. 26, a SQUID based sensor using magnetic nanoparticles.
  • An in-plane magnetic field is applied to de-randomise the magnetic moments of the magnetic nanoparticles attached to an immobilised zone on a substrate.
  • the immobilised zone lies in a well and a Mylar® sheet is described as an example thereof. Then the field is switched off.
  • the relaxation of the magnetic dipoles of the attached nanoparticles according to the Neel mechanism produces a measurable time dependence of the magnetic flux through the SQUID for a period of several seconds.
  • This flux is detected by a SQUID probe placed close to the edge of the immobilised zone.
  • Superparamagnetic nanoparticles in the bulk liquid are free to move according to Brownian motion and produce, in the absence of an applied field, no magnetic field.
  • SQUID flux detectors have the disadvantage that they are expensive and that they operate only at cryogenic temperatures.
  • a magnetoresistive sensor device for determining the presence or an areal density of magnetic nanoparticles being directly or indirectly coupled to the target, the magnetoresistive sensor device comprising a substrate having attached thereto a binding site able to selectively bind a target , and a magnetoresistive sensor for detecting the magnetic field of magnetic nanoparticles at least when coupled to the target , wherein the magnetoresistive sensor comprises pairs of first and second magnetoresistive sensing elements or first and second groups of magnetoresistive sensing elements, each pair being associated with and located parallel with a probe element having at least one binding site, the outputs of the first and second magnetoresistive elements or first and second groups of magnetoresistive sensing elements being fed to a comparator circuit.
  • the present invention also includes a method for determining the presence or for measuring an areal density of magnetic nanoparticles on a substrate, comprising the steps of:
  • the target being directly or indirectly labeled with magnetic nanoparticles
  • the sensing step is carried out by extracting two signals derived from the magnetic field generated by nanoparticles bound to the one binding site using magentoresistive sensors elements; and determining the difference between the two signals.
  • the width and length dimensions of the probe areas that are the areas on the chip at which the probe elements such as antibodies are attached, and of the magneto- resistive (MR) sensor elements, are much larger than the diameter of the magnetic nanoparticles of which the presence and concentration is to be measured.
  • the nanoparticles may for example have a diameter between 1 and 250 nm, preferably between 3 and 100 nm, most preferred between 10 and 60 nm. For such small particles, the diffusion is fast.
  • the width and length dimensions of sensor elements are at least a factor 10 or more, preferably a factor 100 or more, larger than the diameter of the nanoparticles, for example 1 ⁇ m x 1 ⁇ m. Other dimensions for the sensor elements are also possible. If different dimensions are used, different S/N ratios are obtained.
  • micro-array or “biochip” refers to generated arrays on a planar surface that constitute a plurality of discrete reaction or incubation compartments identifiable by their locations or x-y coordinates on the array. Such arrays are suitable for use in assays for assessing specific binding characteristics between members of specific binding pairs. The invention is very suitable in competitive assays or displacement assays.
  • Fig. 1 is a schematic diagram of a BARC chip according to the prior art.
  • Fig. 2 is a graph of the response (resistance) of a multilayer GMR sensor device to an applied field according to the prior art.
  • Fig. 3 is a perspective view of a biochip.
  • Figs. 4A, 4B and 4C show details of a probe element provided with binding sites able to selectively bind target sample, and magnetic nanoparticles being directly or indirectly bound to the target sample in different ways.
  • Fig. 4D shows a schematic of a competitive assay
  • Fig. 5 A is a cross-section of an embodiment of a probe area on the biochip of Fig. 3, according to A- A' in Fig. 3.
  • Fig. 5B is a cross-section of another embodiment of a probe area on the biochip of Fig. 3, according to A- A' in Fig. 3.
  • Fig. 5C is a graph of the response of a multilayer GMR sensor element to an applied field according to the present invention.
  • the dots indicate schematically the punt R(H) values of each magnetoresistive sensor element.
  • Fig. 6 illustrates a set-up in which two coils with a ferromagnetic core are used for magnetizing the magnetic nanoparticles.
  • Fig. 7 is a schematic representation of a Wheatstone bridge.
  • Fig. 8 is a schematic representation of a Wheatstone bridge configuration according to the present invention in which all parts are magnetically equal.
  • Figs. 9A and 9B show a first and a second example respectively of suitable GMR structures for carrying out the present invention.
  • Fig. 10 is a graph showing upper and lower limits of the detectable areal density, as a function of the magnetic particle diameter
  • Fig. 11 is a graph illustrating the x-components of the magnetic field of the nanoparticles in the plane of the GMR sensor elements.
  • Fig. 12 schematically shows a multi-step structure above a plurality of magnetic sensor elements.
  • the biochip area is 1 x 1 mm 2
  • there are 100 different probes on the biochip area each probe having an area (width Wj x length /) of 10 "2 mm 2 (e.g. 100 ⁇ m x 100 ⁇ m)
  • a measurement of the presence or absence of nanoparticles and/or nanoparticle density at each probe element is carried out 100 times during a total period of 3 minutes.
  • a biochip 1 comprises a substrate 3 with at its surface at least one, preferably a plurality of probe areas 5, as shown in Fig. 3.
  • Each probe area 5 comprises a, preferably stripe shaped, probe element 7 over at least part of its surface, as shown in the two embodiments of Fig. 5 A and Fig. 5B, which are explained below.
  • a probe element 7 is provided with binding sites 9, such as for example binding molecules or antibodies, able to selectively bind a target sample 11 such as for example a target molecule species or an antigen.
  • binding sites 9 such as for example binding molecules or antibodies
  • target sample 11 such as for example a target molecule species or an antigen.
  • Any biological molecule that can be coupled to a matrix is of potential use in this application. Examples are:
  • Nucleic acids DNA, RNA double or single stranded or DNA-RNA hybrids, with or without modifications. Nucleic acid arrays are well known. - Proteins or peptides, with or without modifications, e.g. antibodies, DNA or
  • Small molecules such as inhibitors, ligands, cross-linked as such to a matrix or via a spacer molecule
  • the items spotted on the grid will be most likely libraries of compounds, such as peptide/protein libraries, oligonucleotides libraries, inhibitor libraries.
  • sensor molecules 13 labeled with magnetic particles 15 are able to selectively bind a target 11.
  • random searches e.g. screening which DNA binding proteins of a certain tissue extract bind to a grid with a library of nucleotides
  • the sensor molecule should have a very broad specificity.
  • a sensor molecule with a spacer reactive towards amino groups or carboxy groups would be useful.
  • Other sensor molecules with a reactive group towards sugars, DNA are also suitable.
  • tailor-made sensor molecules can be used e.g.
  • a screening with a protein against a protein library is performed for assumed protein-protein interaction
  • an antibody is an obvious choice. Both monoclonal and polyclonal antibodies may be used.
  • magnetic particles 15 are indirectly bound to the target sample 11.
  • the target sample 11 molecules are directly labeled by magnetic nanoparticles 15.
  • target sample 11 is labeled by labels 12.
  • a labeled target sample 11 e.g. biotynilated sample DNA
  • Sensor molecules 13 e.g. streptadivin
  • magnetic nanoparticles 15 are able to selectively bind the labels 12 on the target sample 11. Again, the magnetic nanoparticles 15 are indirectly bound to the target sample 11.
  • Fig. 4D there is a target 11 and a target labeled with magnetic nanoparticles 15 present in the fluid or gas.
  • the target with magnetic nanoparticles is able to selectively bind, if it reaches the binding site 9 earlier than the target reaches the binding site. The more target labeled with magnetic nanoparticles 15 has been bound, the less target was present in the fluid or gas.
  • the magnetic particles 15 are preferably superparamagnetic nanoparticles having a diameter less 1 ⁇ m, having an average magnetic moment m.
  • nanoparticles are meant particles having at least one dimension ranging between 1 nm and 250 nm, preferably between 3 nm and 100 nm, more preferred between 10 nm and 60 nm. They are attached to the probe element 7 on the substrate 3 of the biochip 1, either directly or indirectly, preferably by any of the methods illustrated in Figs. 4A, 4B or 4C or similar.
  • the nanoparticles 15 are usually positioned randomly within a well defined area on the chip 1, the well defined area being a probe area 5.
  • the probe area 5 has a width Wi and a length /.
  • the areal density of the nanoparticles 15 is n (nanoparticles per m 2 ). The areal density will in general be a function of time.
  • the probe area 5 can be a single long stripe. Instead of a single long stripe, also a certain number of shorter stripes next to each other can be used, so that the total area taken by a single probe 5 becomes squarer, more as shown in Fig. 3. As this does not affect the results on electronic sensitivity, only the case of a single long stripe shaped probe area 5 is further elaborated hereinafter.
  • the functioning of the biochip 1 is as follows. Each probe element 7 is provided with binding sites 9 of a certain type. Target sample 11 is presented to or passed over the probe element 7, and if the binding sites 9 and the target sample 11 match, they bind to each other. Subsequently, magnetic nanoparticles 15 are directly or indirectly coupled to the target sample 11, as illustrated in Figs. 4 A, 4B and 4C. The magnetic nanoparticles 15 allow to read out the information gathered by the biochip IThe nanoparticles are preferably superparamagnetic nanoparticles 15 according to the present invention.
  • Superparamagnetic particles are ferromagnetic particles of which at zero applied magnetic field the time- averaged magnetisation is zero due to thermally induced magnetic moment reversals that are frequent on the time scale of the magnetisation measurement.
  • KV with K the magnetic anisotropy energy density and the particle volume
  • v 0 is the reversal attempt frequency (typical value: 10 9 s "1 ).
  • the nanoparticles are magnetised parallel to the plane of the chip.
  • a magnetoresistive (MR) sensor for example a giant magnetoresistive (GMR), a tunnel magnetoresistive (TMR) or an anisotropic magnetoresistive (AMR) sensor is provided according to the present invention to read out the information gathered by the biochip 1, thus to read out the presence or absence of the particles and/or to determine or estimate an areal density of the magnetic nanoparticles 15 on the probe area 5.
  • GMR giant magnetoresistive
  • TMR tunnel magnetoresistive
  • AMR anisotropic magnetoresistive
  • GMR is the magnetoresistance for layered structures with conductor interlayers in between the switching magnetic layers
  • TMR is the magneto-resistance for layered structures comprising magnetic metallic electrode layers and a dielectric interlayer.
  • structures have been developed in which two very thin magnetic films are brought very close together. The first magnetic film is pinned, what means that its magnetic orientation is fixed, usually by holding it in close proximity to an exchange bias layer, a layer of antiferromagnetic material that fixes the first magnetic film's magnetic orientation. The second magnetic layer or free layer, has a free, variable magnetic orientation.
  • Changes in the magnetic field in the present case originating from changes in the magnetisation of the superparamagnetic particles 15, cause a rotation of the free magnetic layer's magnetic orientation, which in turn, increases or decreases resistance of the entire sensor structure.
  • Low resistance generally occurs when the sensor and pinned layers are magnetically oriented in the same direction.
  • Higher resistance occurs when the magnetic orientations of the sensor and pim ed films oppose each other.
  • TMR can be observed in systems made of two ferromagnetic electrode layers separated by an isolating (tunnel) barrier. This barrier must be very thin, i.e., of the order of lnm. Only then, the electrons can tunnel through this barrier, an entirely quantum- mechanical transport process.
  • the magnetic alignment of one layer can be changed without affecting the other by making use of an exchange bias layer.
  • Changes in the magnetic field in the present case again originating from changes in the magnetisation of the superparamagnetic particles 15, cause a rotation of the sensor film's magnetic orientation, which in turn, increases or decreases resistance of the entire sensor structure.
  • the AMR of ferromagnetic materials is the dependence of the resistance on the angle the current makes with the magnetisation direction. This phenomenon is due to an asymmetry in the electron scattering cross section of ferromagnet materials.
  • the magnetoresistive sensor e.g. a GMR sensor
  • the magnetoresistive sensor comprises a first sensor element, e.g. a GMR element 17 and a second sensor element, e.g. a GMR element 19 integrated in the biochip substrate 3 at a distance d under the surface of the substrate 3.
  • a first sensor element e.g. a GMR element 17
  • a second sensor element e.g. a GMR element 19 integrated in the biochip substrate 3 at a distance d under the surface of the substrate 3.
  • Each of those GMR elements 17, 19 comprises a pinned film with the same magnetisation direction, parallel or substantially parallel to the x-direction, and a free film or sensor film, the magnetisation direction of which is able to change due to an external magnetic field.
  • the superparamagnetic nanoparticles 15 bound to it are magnetised by an external, uniform magnetic field perpendicular to the plane of the biochip 1.
  • the use of the perpendicular magnetic field creates a net, average, magnetic fieldat the two sides of the stripe shaped area covered by the nanoparticles close to the sensor elements 17, 19.
  • the probe areas overlap only with half of the GMR sensor stripes, so that the net average field in the sensor stripes created by the nanoparticles is largest along or near the central axis of the stripes.
  • the magnetised nanoparticles 15 produce regions of opposite magnetic induction vectors in the plane of the underlying GMR films, as shown in Fig. 11, and the resulting magnetic field is detected by GMR sensor elements 17, 19.
  • a co-ordinate system has been introduced in Fig. 3 and in
  • the probe element 7 and the GMR elements 17, 19 extend in the y direction over a length /. If the magnetoresistive sensor elements 17, 19 lie in the xy plane, the GMR sensor elements 17, 19 only detect the x- component of the magnetic field. The resulting magnetic field from the magnetised superparamagnetic particles 15 is detected by the first GMR element 17 and the second GMR element 19. Over the width W of probe element 7, the limited (non-infinite) spatial extent of the magnetic particles contributes to a net signal generated by the magnetic field in the plane of the GMR elements 17, 19.
  • the magnetic particles at the edges of the probe element have no particles next to them on one side and therefore the magnetic field from these particles has a net in-plane field component in one direction within the sensor elements 17. 19. Particles which lie closer to the centre of a sensor 17, 19 will have their in-plane magnetic field neutralised to a certain extent by neighbouring particles on both sides. Thus all particles contribute to the signals generated in the sensor elements 17, 19. Although all nanoparticles make some contribution to the net field, the particles close to the probe element edges contribute more to the total magnetic field. Because a magnetic sensor element 17, 19 is most sensitive in the centre, the magnetic nanoparticles 15 at the edges of probe element 7 preferably are, in perpendicular projection, in the centre of the sensor elements 17, 19.
  • the functioning of the sensor does not depend critically on the distance W between the GMR stripes, which can be chosen much larger than the diameter of the nanoparticles.
  • the pinned films in the first GMR element 17 and the second GMR element 19 may both be oriented in the positive x-direction.
  • the magnetisation direction of the free film or sensor film of the first GMR element 17 will also be in the positive x-direction, and the magnetisation direction of the free films of the second GMR element 19 will be in the negative x-direction.
  • the magnetisation directions of the pinned film and of the free film of the first GMR element 17 being the same, the first GMR element 17 exhibits a low resistance.
  • the second GMR element 19 exhibits a high resistance.
  • the responses of the first GMR element 17 and the second GMR element 19 to the magnetic field present due to the magnetisation of the nanoparticles are shown in Fig. 5C (a) and (b) respectively.
  • the magnetic field is either in the parallel or antiparallel direction compared with the biasing of the GMR element depending upon where the nanoparticle is placed.
  • the external magnetisation of the nanoparticles 15 can be done in any way known to a person skilled in the art. In particular it can be done by means of two coils 30 with a ferromagnetic core 32, as shown in Fig. 6. By applying a current of about 10 mA, for example, a magnetic field is generated, which is perpendicular to the substrate, in order to magnetise and align the magnetic moments of the nanoparticles 15.
  • both coils 30 are positioned along one line perpendicular to the substrate 3, if the coil diameter is approximately equal to or larger than the distance between the coils, and if the currents through the two coils are equal the magnetic field applied is to a good approximation perpendicular to the substrate 3 over an area equal to the coil area,. It can be useful to create the option for varying the position ofthe coils such that a linear gradient of the magnetic field occurs at the probe area, by having a small (x . y.z) translation of one or both coils Alternatively, a gradient could be created by making use of a current difference..
  • the surface of the probe area 5 has a buffer or isolation zone which prevents or reduces the effect of any nanoparticles accidentally in this zone from affecting the measurement.
  • the surface of the semiconductor sensor element can be structured.
  • the purpose of the structuring can be to move the particles so far from the sensors that they no longer influence the measurement.
  • Such structuring can be done physically, for example by means of a step profile or, as shown in Fig. 5B, with a gradient profile, e.g. by etching the semiconductor materials of the sensing element using anisotropic or isotropic etching solutions, e.g. to form a well.
  • the probe area can be surrounded by a trench, deep enough to isolate any nanopartciles from the sensors.
  • the surface of the probe area 5 can also be chemically or biochemically structured, e.g. by providing binding sites on probe element 7 of the probe area 5, but not on the regions 8 of the probe area located next to the probe element 7. Repellent materials may be used for these buffer zones.
  • the sensor is separated from the magnetic nanoparticles 15 by a separation layer 40, e.g. silicon dioxide, silicon nitride, or an organic material such as a resist or epoxy for example.
  • the magnetisation of the nanoparticles 15 is controlled by an external field applied perpendicular to the surface of the biochip 1 (i.e. along the z-axis).
  • the sensor is now exposed to the magnetic field resulting from the nanoparticles 15, of which the (stripe- averaged) in-plane component is is particularly high below the sides of the probe region covered with the magnetic nanoparticles.
  • the change of the resistance difference of the sensors 17, 19, upon the application of a perpendicular magnetic field, is used to measure the areal density of nanoparticles on the probe element.
  • the areal density of the magnetic nanoparticles 15 on the lower surface, probe element 7a is given by density ⁇ ⁇ , and on the upper surface by density ⁇ .
  • a recessed probe region reduces the sensitivity to magnetic beads that reside on the surface at positions outside the probe area, i.e. without being specifically bound to probe molecules.
  • an additional washing step can be applied, or particles can be pulled away from the sensor surface by the application of a magnetic field and a magnetic field gradient.
  • the areal particle density typically ranges between zero and 10 3 to 10 4 particles per ⁇ m 2 .
  • the areal particle density typically ranges between zero and 10 3 to 10 4 particles per ⁇ m 2 .
  • it is relatively easy to fabricate micrometer or sub-micrometer sized physical structures on surfaces, while it is much more difficult to fabricate high-quality biochemical surfaces with micrometer or submicrometer patterns.
  • the senor consists of a pair of sensor elements 17 and 19 in a configuration with respect to a probe area as shown in fig. 5B.
  • the areal density of magnetic nanobeads is derived from the difference of the resistance changes of the two sensor elements 17 and 19 upon the application of a perpendicular magnetic field.
  • sensor element 17 and 19 are equally sensitive to the effects of an in-plane component of the external field or due to thermal drift, these unwanted effects are cancelled.
  • a practical method for obtaining the signal is to use sensors 17 and 19 as elements a and b in a Wlieatstone bridge, as shown schematically in fig.
  • the elements c and d are taken to be either (approximately) equal non-magnetic resistors, or magnetoresistors of the same type as sensors a and b, for which the resistance does not change in the applied field.
  • This can be accomplished e.g. by applying no probe molecules close to sensors c and d or by, applying probe molecules above c and d sensors to a region that is much wider than the total width of the c and d sensor area (so that the net effect of all the dipolar fields is zero), or by locally applying a thick cover layer on top of sensors c and d so that the sensitivity to the presence of magnetic particles is strongly reduced. It is not necessary that the sensors c and d have the same physical dimensions as sensors a and b. Irrespective of the detailed practical method used for obtaining the signal we will call such a system a half- Wheatstone bridge.
  • the sensitivity of a full Wheatstone bridge is twice the sensitivity of an otherwise identical half Wheatstone bridge.
  • the output of the comparator provides for example an indication of whether nanoparticles are present (when it exceeds a minimum threshold) or can be used to determine or estimate the areal density of the particles.
  • a substantially linear and hysteresis free resistance versus field curve can be obtained by making use of a magnetic confuguration for which the exchange bias direction is perpendicular to the length direction (current direction), and for which the easy magnetization direction of the free layer is parallel to the length direction.
  • the external field to which the sensor is sensitive is directed perpendicular to the stripe length direction.
  • the field range ('switch field') in which the magnetization of the free layer rotates from a direction parallel to a direction antiparallel to the direction of the 'pinned' exchange biased layer is determined by the combination of various contributions to the magnetic anisotropy, including an intrinsic contribution that can e.g.
  • the coupling due to pinholes in the interlayer, the interlayer exchange coupling, and the magnetostatic coupling due to non-flat magnetic metal/interlayer interfaces can be reduced by making use of interlayers that are sufficiently thick.
  • the magnetostatic coupling related to the finite stripe width can e.g.
  • a first example of a suitable GMR structure 60 for a sensor device according to the present invention is as shown in Fig. 9A.
  • the GMR structure 60 comprises a thermally oxidised Silicon substrate 61 having a major surface 62.
  • a stack of layers is applied being first a (plurality of) buffer layer(s) 63, an antiferromagnet (AF) 64, a pinned ferromagnet (F p i nn e d ) 65, a non-magnetic material (NM) 66, a free ferromagnet (F free ) 67 and a cover layer 68.
  • AF antiferromagnet
  • NM non-magnetic material
  • F free F free ferromagnet
  • cover layer 68 cover layer 68.
  • each of the mentioned layers may consist of the following materials and thicknesses:
  • buffer layer 63 a 3 nm thick Ta layer 63 a with on top thereof a 3 nm thick Ni 80 Fe 20 layer 63b, - for the AF 64: a 10 nm thick hr 20 Mn 8 o layer,
  • the Ir 20 Mn 80 layer 64 is an antiferromagnet (AF) which causes the magnetisation of the Co layer 65 to be pinned in a direction perpendicular to the length as of the GMR stripes 17, 19. This is done by growing the Co layer 65 in a magnetic field, or by cooling the system, after growing, in a magnetic field from a temperature above the so-called 'blocking temperature' (which is for the materials under consideration about 300° C).
  • the Cu layer 66 separates the pinned Co layer 65 from the free Ni 80 Fe 20 layer 67.
  • the upper Ta layer 68 protects the GMR structure 60 against oxidation when the wafer is exposed to air after deposition.
  • the lower Ta layer 63 a and the abutting Ni 80 Fe 20 layer 63b aid in building or growing a suitable microstructure and crystal orientation.
  • a second example of a suitable GMR structure 69 is shown in Fig. 9B.
  • the GMR structure 69 comprises a thermally oxidised Silicon substrate 61 having a major surface 62. On the major surface 62 of the substrate 61, a stack of layers is applied being first a (plurality of) buffer layer(s) 63, then an artificial antiferromagnet (AAF) 70, anon-magnetic material (NM) 66, a free ferromagnet (F free ) 67 and a cover layer 68.
  • AAF artificial antiferromagnet
  • NM anon-magnetic material
  • F free free
  • cover layer 68 a cover layer 68.
  • each of the mentioned layers may consist of the following materials and thicknesses:
  • - for the buffer layer 63 a 3 nm thick Ta layer 63a with on top thereof a 3 nm thick Ni 80 Fe 20 layer 63b
  • - for the AAF 70 an AF layer, e.g. a 10 nm thick Ir 20 Mn 80 layer 70a, a 6 nm thick Co layer 70b, a 0.8 nm Ru layer 70c and a 6 nm Co layer 70d,
  • the AAF layer 70 has the form of AF/Co/Ru/Co.
  • the thickness of the Ru layer 70c is chosen so as to cause the magnetisation directions of the two Co layers 70b, 70d to be antiparallel due to exchange coupling over the Ru layer 70c.
  • the AF layer 70a causes the magnetisations of the two Co layers 70b, 70d to be perpendicular to the length axis of the GMR stripes 17, 19.
  • This second GMR structure 69 has as advantage over the first GMR structure
  • an adjustable coupling between the pinned layer 70d and the free layer 67 can be chosen. This can compensate for a small coupling over the Cu layer 66 between the pinned layer 70d and the free layer 67.
  • the sum of all couplings is chosen to be essentially zero, so that at zero applied field (no particles) the magnetisation of the free layer 67 is exactly perpendicular to the one of the pinned layer 70d (and thus parallel to the axis of the stripe 17, 19).
  • the magnetostatic field from the AAF 70 of which the sign and size can be varied by varying by the difference of the thicknesses of the layers 70b and 70d, it is possible to correct for this, what leads to more sensitivity of the MR sensor device.
  • the diameter of the nanoparticles 15 (not shown in Fig. 3) is much smaller than W. With much smaller is meant at least a factor 10, preferably a factor 100 or more smaller.
  • In-plane magnetisation causes an in-plane magnetic field in the sensor elements 17, 19.
  • This in-plane magnetic field is however, not as strong as the magnetic field close to the ends of the magnetic dipoles and therefore the sensitivity of this technique is lower.
  • the magnetic field from the nanoparticles that is measured is also due to the slow decay (thermal relaxation) of the magnetisation of those particles that are bound to the probe.
  • the decay of the magnetisation from unbound particles is also much faster, due to their fast random rotational motion. Soon after switching off the applied field, their net magnetisation is therefore negligible.
  • the sensor device may be equipped with means for generating either a magnetic field perpendicular to the plane of the probe element (modes 1 and 2) or a magnetic field parallel to the plane of the probe element in the plane of the nanoparticles (mode 3) or optionally both when desired.
  • switches may be provided to be able to measure the resistances of the sensor stripes separately, or e.g. to be able to measure sums or differences of resistances.
  • the required magnetic properties of the superparamagnetic particles 15, more specifically their relaxation time distribution, are different for the different modes, as discussed below.
  • the total width W occupied by a probe area 5 is given by the width W of each probe element 7, half of the width of each of the two GMR elements 17, 19, plus a margin in order to eliminate cross-field effects, and that margin is taken 5 ⁇ m, there is sufficient space on a biochip 1 of 1 x 1 mm 2 for 100 probe areas 5 next to each other.
  • the stripe-averaged field in case of a lot of particles per unit area, for nanoparticles 15 with magnetisation along the positive z-axis, is indicated schematically by the field lines in Figs. 5 A and 5B. It is equal to a magnetic field due to two parallel current wires at the edges of the stripes, with a current
  • the GMR elements 17, 19 probe the x-component of the magnetic field, which is positive for the first GMR element 17 and negative for the second GMR element 19. If the origin of the coordinate system is taken in the middle of the first GMR element 17, then the average x-component of the field in that element 17
  • the pair of GMR elements 17, 19 in which the signal is opposite can be used to make a Wheatstone bridge configuration in which all parts are magnetically equal, that is in which there are equal exchange bias directions in all branches.
  • An example of such a Wheatstone bridge is given in Fig. 8.
  • the signal doubles, due to the elimination of a non- active reference MR element, and a common mode signal (e.g. due to in-plane external fields or due to thermal drift) is cancelled.
  • the signal voltage is given by: ⁇ R ⁇ H.
  • ( ⁇ H) max is the field range in which the element switches completely. If shape anisotropy determines this range,
  • the electronic noise is assumed to be due to thermal noise.
  • the r.m.s. thermal noise voltage is:
  • V N 4kTRAf where the effective measurement time t meas is equal to the time during which the signal is measured, provided that just before the measurement the magnetisation can be assumed to be zero (because the particles are superparamagnetic). That defines a reference level.
  • the superparamagnetic relaxation time of all particles is much smaller, at least a factor 5 smaller, preferably a factor 10 or more smaller, than the period of time during which the field is applied and during which the measurement is carried out.
  • the magnetisation of the particles is then switched on and off almost instantaneously upon switching the field on and off. In that case, the magnetic dipolar interaction between the particles after a measurement is negligible, and the binding reaction can proceed without being disturbed by such interactions in between the measurements.
  • the magnetic particles in the nanobeads should have a product of the volume V and the magnetic anisotropy constant K that is sufficiently small, hi this first mode of operation, the particles 15 that are not bound to the chip 1 should not be present at the chip interface during a measurement. This can be accomplished by a washing step just before each measurement, or by temporarily displacing the non-bound particles away from the chip 1 just after the application of a field plus a field gradient parallel to the normal direction. The resulting force should be sufficient for displacing the particles a few micrometers above the chip surface (where their dipolar field at the surface is small, and where their positions with respect to the GMR elements 17, 19 is sufficiently random, so that also for this reason the net signal is negligible). On the other hand, the force should be less than the force required for breaking a bond.
  • the relaxation time should be between 1 ms and 1 s (see below). This is a more difficult requirement than for the first mode of operation. Particles that fall outside this range do not contribute to the signal, and should ideally not be present. The particle diameter should therefore be to a very good approximation monodisperse.
  • a method for creating such particles is known, and is described in S. Sun et al., "Monodisperse FePt Nanoparticles and Ferromagnetic Nanocrystal Superlattices", Science 287, 1989-1992 (2000).
  • the SNR is calculated for a system as specified by the table below, giving the system parameters for the example, for 35 nm commercially available magnetic particles, such as magnetite (Fe O 4 ) particles.
  • the moment m indicated is the saturation moment, which is already obtained when the applied field is higher than 1.2 kA/m.
  • the voltage over each MR element is 10 N.
  • the power during a measurement, per probe, is 20 mW.
  • V s 8.8x10 -16 II
  • v N ⁇ .3 ⁇ ⁇ : ⁇ -' x J
  • n min 1.5xl0 8
  • the maximum measurable areal density of particles is equal to the lowest of the following two densities:
  • the density above which the magnetic dipolar interaction between the particles, or steric hindrance, becomes too strong For 35 nm particles this may be at a density of the order of 100 particles per ⁇ m 2 .
  • the time averaged power dissipation is 2 mW for the first mode of operation, assuming 100 probes and a duty cycle of 1 : 1000 for each probe (one measurement per second, with a duration of 1 ms).
  • the power dissipation isp x 2 mW, where ? is the number of 1 ms measurement intervals per cycle.
  • 1/f noise may become important, especially if the period over which the decay of the signal is measured becomes as long as 1 s.
  • the above results can be generalised as follows.
  • the areal density of particles that can be detected should not be below the density rc-(stat) that corresponds to the statistically determined value of «50 particles per probe, below which the above theory breaks down.
  • n-(stat) 0.005/ ⁇ m 2 .
  • the areal density of particles that can be measured is certainly lower than the density w + (int) at which interparticle interactions or steric hindrance become too large. It is assumed that « + (int) « 1.25 x 10 5 /d 2 , d being the particle diameter in nm. So, independent of the sensitivity of the GMR elements used, the measurement time and the magnetic moments of the particles, the highest possible width of the dynamic range is:
  • the use of small particles is advantageous, as it increases the width of the dynamic range.
  • the value of w-(sens) is inversely proportional to the particle volume and to the squareroot of the measurement time.
  • the actual upper limit of the density is not given by « + (int) but by the density « + (satur) at which the GMR element saturates, if w + (satur) ⁇ n + (int)_
  • « + (satur) 4.11 x 10 7 / 3 .
  • Fig. 10 is a graph showing areal density (in particles/ ⁇ m 2 ) as a function of theparticle diameter (in nm). From the diagram the dynamic range can be derived for the system considered, as a function of the magnetic particle diameter, for the parameter values given in the table above, and for a measurement time of 1 ms. The upper limits of the dynamic range are given for higher particle diameters by n + (satur), which is due to saturation of the magnetoresistive element, and for lower particle diameters by n+(int), which is due to interparticle interactions or steric hindrance.
  • the lower limits of the dynamic range are given for higher particle diameters by n-(stat), which is due to the statistical (random) position of the particles on the probe area, and for lower particle diameters by n-(sens), which is due to sensitivity of the magnetoresistive element.
  • the overall upper sensitivity limit is given by line 30, and the overall lower sensitivity limit is given by line 31.
  • the dynamic range for 35 nm particles is given by the double arrow 32. It can be seen from Fig. 10 that, for the measurement time of 1 ms assumed, the particle radius of 35 nm is optimal. A decrease of the MR element saturation field or an increase of the particle magnetisation lead to parallel downward shifts of the n.(sens) and n + (satur) lines. Separately or in combination, these two improvements of the system could shift the optimal diameter to at best approximately 10 nm, leading to a dynamic range of 2 x 10 5 .

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Dispersion Chemistry (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Ecology (AREA)
  • Investigating Or Analyzing Materials By The Use Of Magnetic Means (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)

Abstract

The present invention relates to a method and a device for magnetic detection of binding of biological molecules on a biochip. A magnetoresistive sensor device for measuring an areal density of magnetic nanoparticles on a micro-array, the magnetic nanoparticles (15) being directly or indirectly coupled to the target sample (11), is described. The magnetoresistive sensor device comprises a substrate (3) having attached thereto binding sites (9) able to selectively bind target sample (11), and a magnetoresistive sensor for detecting the magnetic field of the nanoparticles (15) coupled to the target sample. The magnetoresistive sensor comprises a plurality of magnetoresistive sensing elements (17, 19), the width and length dimensions of which are at least a factor 10 or more, preferably a factor 100 or more larger than the diameter of the nanoparticles (15). A corresponding method is described as well.

Description

Sensor and method for measuring the areal density of magnetic nanoparticles on a micro- array
The present invention relates to a method and apparatus for sensing of randomly positioned nanometer-scale magnetic particles. In particular it relates to magnetic detection apparatus and a method for binding of biological molecules on a micro-array or biochip. The introduction of micro-arrays or biochips is revolutionising the analysis of
DNA (desoxyribonucleic acid), RNA (ribonucleic acid) and proteins. Applications are e.g. human genotyping (e.g. in hospitals or by individual doctors or nurses), bacteriological screening, biological and pharmacological research.
Biochips, also called biosensor chips, biological microchips, gene-chips or DNA chips, consist in their simplest form of a substrate on which a large number of different probe molecules are attached, on well defined regions on the chip, to which molecules or molecule fragments that are to be analysed can bind if they are perfectly matched. For example, a fragment of a DNA molecule binds to one unique complementary DNA (c-DNA) molecular fragment. The occurrence of a binding reaction can be detected, e.g. by using fluorescent markers that are coupled to the molecules to be analysed. This provides the ability to analyse small amounts of a large number of different molecules or molecular fragments in parallel, in a short time. One biochip can hold assays for 1000 or more different molecular fragments. It is expected that the usefulness of information that can become available from the use of biochips will increase rapidly during the coming decade, as a result of projects such as the Human Genome Project, and follow-up studies on the functions of genes and proteins.
One method for electronically detecting binding of sample molecules to probe molecules has been demonstrated by Clinical Micro Sensors (CMS), a subsidiary of Motorola, and is described in D.H. Farkas, "Bioelectric detection of DNA and the automation of molecular diagnostics", The Journal of the Association for Laboratory Automation, volume 4, number 5 (1999), pp.20-24. They have developed a "bioelectric DNA detection chip". The principle requires the use of ferrocene label molecules, which are sources or sinks of electrons. Capture probes are attached to gold-coated electrodes on the biochip. Capture probes are single strands of DNA complementary to a unique region of the target DNA or RNA sequence. When a sample containing target DNA is introduced into the cartridge, specific capture probes on an electrode surface encounter complementary DNA from the sample. Then binding, or hybridisation, occurs. The system also contains DNA sequences, called signaling probes, with proprietary electronic labels attached to them. These signaling probes also bind to the target DNA sequence. Binding of the target sequence to both the capture probe and the signaling probe connects the electronic labels to the surface. Binding of a molecular fragment is detected by the occurrence of an AC current through an electrode on which the molecules are bound, when a slight AC voltage is applied between the electrode and the solution above the chip, because the labels release electrons, producing a characteristic signal that can be detected through the electrode. This indicates the presence of the target DNA. Within this concept, the signal is proportional to the absolute number of binding reactions that have taken place. The number of electrons that flow, per cycle, and per bound DNA/c-DNA pair, is very small (a few, or a few tens). The above-mentioned paper mentions that in practice currents are in the pA to μA range, unfortunately without specifying the electrode area or the absolute number of bound pairs (presumably very large numbers). Proprietary signal processing technology is used to identify and quantify the target DNA sequence.
A second principle is a Bead Array Counter (BARC) biochip, as described in
D.R. Baselt, "A biosensor based on magnetoresistance technology", Biosensors & Bioelectronics 13, 731-739 (1998); in R.L. Edelstein et al, "The BARC biosensor applied to the detection of biological warfare agents", Biosensors & Bioelectronics 14, 805 (2000); and in M.M. Miller et al., "A DNA array sensor utilizing magnetic microbeads and magnetoelectronic detection", Journal of Magnetism and Magnetic Materials 225 (2001), pp.138-144.
Using magnetoresistive materials, a rugged, single-component, micro- fabricated detector is produced, that will simultaneously monitor hundreds, thousands or even millions of experiments. As shown in Fig. 1, the detector 100 has an array of many micron- sized magnetoresistive sensors 101. For clarity, only two probe sites, each with one GMR sensor, are shown. These sensors 101 are located at a very small depth (= thickness of the silicon nitride Si3N passivation layer 102 combined with that of a relatively thin gold layer 103) below the surface of the substrate to which two probe DNA 104 is attached. Biotinylated sample DNA 105 binds to the probe DNA 104, if the nucleotide sequences the pairs formed are complementary. To the solution free-floating magnetic streptavidin coated micro-beads 106 are added, after probe-sample DNA hybridization has taken place. The beads bind to the sample DNA that has hybridized with probe DNA by the formation of a streptavidin-biotinyl bond. So if sample DNA 105 having sequences complementary to both probes 104 is present, the sample DNA 105 will attach the beads 106 to the sensors 101. The beads 106 used have a diameter of the order of 1 μm. In the beads 106, nanometer scale magnetic particles are present (not represented in the drawing), which are superparamagnetic due to their small size. Those nanometer-sized particles are typically of iron oxide, and are dispersed in, layered onto, or coated with a polymer or silica matrix to form beads of about 1 μm in diameter. Non-binding beads are taken away by making use of a small magnetic field in combination with a small field gradient or by rinsing with a buffer solution. The presence of the binding beads on the biochip is then detected by magnetising the particles in a relatively small, known, external magnetic field that is directed perpendicular to the plane of the substrate. Although the example given above is for detection of DNA, also other molecules such as e.g. proteins can be detected by means of the prior art BARC biochip.
In the above-mentioned articles, the presence of particles is detected by making use of giant magnetoresistive (GMR) half Wheatstone bridge type sensors in the substrate, with a resistance versus applied field curve as shown in figure 2. The half Wheatstone bridge consists of one sensitive part above which beads are present, and one reference part above which no beads are present. The resistance versus field curve of the GMR material used is almost symmetric around zero field, as shown in Fig. 2, so that the sign of the field direction is not measured. The resistance of the GMR material decreases by about a same amount in response to a positive or negative applied field. It can be seen from Fig. 2 that there is a certain hysteresis in the GMR material, which is particularly manifest close to zero field. Consequently, accurate detection of small magnetic fields is almost impossible.
The BARC biochipconcept works, but the results given in Fig. 9 of D.R. Baselt, "A biosensor based on magnetoresistance technology", Biosensors & Bioelectronics 13, 731-739 (1998) show a poor signal-to-noiseratio(SNR). The main problem is that the large (1 μm scale) beads used diffuse slowly through the solution, so even after a relatively long time allowed for binding between the beads and the sample DNA only a relatively small number of beads will have bound to hybridized sample molecules, leading to a weak signal. Secondly, the beads have a certain distribution of their magnetic moment (at a given field), which negatively affects the signal-to-noise ratio when only one or a few beads are present per sensor. As shown by the authors, the signal-to-noise ratio for measurement of a single bead could be enhanced by making use of smaller sensor surface areas. However, when many sensors per probe are used the electronic circuitry that is required becomes very complex. Furthermore, the slow Brownian motion of the large magnetic particles of about 1 μm means that it can take a long time before the magnetic particle reaches a binding site. Thus actual measurements take a long time.
Tondra et al. describe in "Model for detection of immobilized superparamagnetic nanosphere assay labels using giant magnetoresistive sensors", J. Vac. Sci. Technol. A 18(4), Jul/Aug 2000, pp.1125-1129, that a GMR sensor can detect a single paramagnetic bead of any size, as long as a certain conditions are met, one of which is that the sensor is about the same size as the bead. This condition is easily met at a bead radius of 500 nm. Reducing the bead radius to 100 nm is possible by overcoming technical difficulties in fabrication of GMR sensors. Reducing the bead radius further to 10 nm is said to require advances in bead fabrication technology as well as in GMR sensor fabrication. A disadvantage of this solution is the required precise positioning of the probe areas with respect to the GMR sensor, on a scale well below 0.5 μm.
Chemla et al. describe in the article "Ultrasensitive magnetic biosensor for homogeneous immunoassay", PNAS, December 19, 2000, vol. 97, no. 26, a SQUID based sensor using magnetic nanoparticles. An in-plane magnetic field is applied to de-randomise the magnetic moments of the magnetic nanoparticles attached to an immobilised zone on a substrate. The immobilised zone lies in a well and a Mylar® sheet is described as an example thereof. Then the field is switched off. The relaxation of the magnetic dipoles of the attached nanoparticles according to the Neel mechanism produces a measurable time dependence of the magnetic flux through the SQUID for a period of several seconds. This flux is detected by a SQUID probe placed close to the edge of the immobilised zone. Superparamagnetic nanoparticles in the bulk liquid are free to move according to Brownian motion and produce, in the absence of an applied field, no magnetic field. SQUID flux detectors have the disadvantage that they are expensive and that they operate only at cryogenic temperatures.
It is an object of the present invention to provide a method and device for accurate detection of magnetic particles in biochips with an enhanced signal to noise ratio. It is another object of the present invention to provide a fast method for detection of magnetic particles in biochips and a corresponding device.
It is still another object of the present invention to provide a method and device for detection of magnetic particles, which are simple and economical, and in particular which do not require a precise positioning of individual magnetic beads with regard to the sensors.
The above objectives are accomplished, according to the present invention, by a magnetoresistive sensor device for determining the presence or an areal density of magnetic nanoparticles being directly or indirectly coupled to the target, the magnetoresistive sensor device comprising a substrate having attached thereto a binding site able to selectively bind a target , and a magnetoresistive sensor for detecting the magnetic field of magnetic nanoparticles at least when coupled to the target , wherein the magnetoresistive sensor comprises pairs of first and second magnetoresistive sensing elements or first and second groups of magnetoresistive sensing elements, each pair being associated with and located parallel with a probe element having at least one binding site, the outputs of the first and second magnetoresistive elements or first and second groups of magnetoresistive sensing elements being fed to a comparator circuit.
The present invention also includes a method for determining the presence or for measuring an areal density of magnetic nanoparticles on a substrate, comprising the steps of:
- binding a target to selective binding sites on the substrate, the target being directly or indirectly labeled with magnetic nanoparticles,
- sensing the presence of the bound magnetic nanoparticles to a binding site to thereby determine the presence or density of the target labeled with magnetic nanoparticles - wherein the sensing step is carried out by extracting two signals derived from the magnetic field generated by nanoparticles bound to the one binding site using magentoresistive sensors elements; and determining the difference between the two signals. The width and length dimensions of the probe areas, that are the areas on the chip at which the probe elements such as antibodies are attached, and of the magneto- resistive (MR) sensor elements, are much larger than the diameter of the magnetic nanoparticles of which the presence and concentration is to be measured. The nanoparticles may for example have a diameter between 1 and 250 nm, preferably between 3 and 100 nm, most preferred between 10 and 60 nm. For such small particles, the diffusion is fast. The width and length dimensions of sensor elements are at least a factor 10 or more, preferably a factor 100 or more, larger than the diameter of the nanoparticles, for example 1 μm x 1 μm. Other dimensions for the sensor elements are also possible. If different dimensions are used, different S/N ratios are obtained.
The term "micro-array" or "biochip" refers to generated arrays on a planar surface that constitute a plurality of discrete reaction or incubation compartments identifiable by their locations or x-y coordinates on the array. Such arrays are suitable for use in assays for assessing specific binding characteristics between members of specific binding pairs. The invention is very suitable in competitive assays or displacement assays. These and other features and advantages of the present invention will become apparent from the following detailed description, taken in conjunction with the accompanying drawings, which illustrate, by way of example, the principles of the invention. This description is given for the sake of example only, without limiting the scope of the invention. The reference figures quoted below refer to the attached drawings.
Fig. 1 is a schematic diagram of a BARC chip according to the prior art. Fig. 2 is a graph of the response (resistance) of a multilayer GMR sensor device to an applied field according to the prior art.
Fig. 3 is a perspective view of a biochip. Figs. 4A, 4B and 4C show details of a probe element provided with binding sites able to selectively bind target sample, and magnetic nanoparticles being directly or indirectly bound to the target sample in different ways.
Fig. 4D shows a schematic of a competitive assay
Fig. 5 A is a cross-section of an embodiment of a probe area on the biochip of Fig. 3, according to A- A' in Fig. 3.
Fig. 5B is a cross-section of another embodiment of a probe area on the biochip of Fig. 3, according to A- A' in Fig. 3.
Fig. 5C is a graph of the response of a multilayer GMR sensor element to an applied field according to the present invention. The dots indicate schematically the punt R(H) values of each magnetoresistive sensor element.
Fig. 6 illustrates a set-up in which two coils with a ferromagnetic core are used for magnetizing the magnetic nanoparticles.
Fig. 7 is a schematic representation of a Wheatstone bridge. Fig. 8 is a schematic representation of a Wheatstone bridge configuration according to the present invention in which all parts are magnetically equal.
Figs. 9A and 9B show a first and a second example respectively of suitable GMR structures for carrying out the present invention. Fig. 10 is a graph showing upper and lower limits of the detectable areal density, as a function of the magnetic particle diameter
Fig. 11 is a graph illustrating the x-components of the magnetic field of the nanoparticles in the plane of the GMR sensor elements.
Fig. 12 schematically shows a multi-step structure above a plurality of magnetic sensor elements.
In the different drawings, the same reference figures refer to the same or analogous elements.
The present invention will be described with respect to particular embodiments and with reference to certain drawings but the invention is not limited thereto but only by the claims. For example, the present invention will be described with reference to two magnetoresistive sensor elements for each probe element but the present invention is not limited thereto. For example, 4, 6 or more even numbers of sensor elements may be used for each probe element and split into two groups. An output from each group is then transferred to a differential comparator or a summing circuit. The drawings described are only schematic and are non-limiting. The drawings are not drawn to scale.
The detailed description hereinafter gives a non-limiting example with the following specification: a) the biochip area is 1 x 1 mm2, b) there are 100 different probes on the biochip area, each probe having an area (width Wj x length /) of 10"2 mm2 (e.g. 100 μm x 100 μm), c) a measurement of the presence or absence of nanoparticles and/or nanoparticle density at each probe element is carried out 100 times during a total period of 3 minutes.
The present invention is not limited to such a system with the dimensions and values given, but is only limited by the claims.
A biochip 1 comprises a substrate 3 with at its surface at least one, preferably a plurality of probe areas 5, as shown in Fig. 3. Each probe area 5 comprises a, preferably stripe shaped, probe element 7 over at least part of its surface, as shown in the two embodiments of Fig. 5 A and Fig. 5B, which are explained below.
As shown in Figs. 4A, 4B and 4C, 4D a probe element 7 is provided with binding sites 9, such as for example binding molecules or antibodies, able to selectively bind a target sample 11 such as for example a target molecule species or an antigen. Any biological molecule that can be coupled to a matrix is of potential use in this application. Examples are:
- Nucleic acids : DNA, RNA double or single stranded or DNA-RNA hybrids, with or without modifications. Nucleic acid arrays are well known. - Proteins or peptides, with or without modifications, e.g. antibodies, DNA or
RNA binding proteins. Recently, grids with the complete proteome of yeast have been published.
- Oligo- or polysaccharides or sugars
- Small molecules, such as inhibitors, ligands, cross-linked as such to a matrix or via a spacer molecule
The items spotted on the grid will be most likely libraries of compounds, such as peptide/protein libraries, oligonucleotides libraries, inhibitor libraries.
There exist different possibilities to connect magnetic nanoparticles 15 to the target 11, examples of which are shown in Figs. 4A, 4B,4C and 4D. In Fig. 4A, sensor molecules 13 labeled with magnetic particles 15 are able to selectively bind a target 11. When random searches are performed, e.g. screening which DNA binding proteins of a certain tissue extract bind to a grid with a library of nucleotides, the sensor molecule should have a very broad specificity. In this example a sensor molecule with a spacer reactive towards amino groups or carboxy groups would be useful. Other sensor molecules with a reactive group towards sugars, DNA are also suitable. In the case of a direct search, tailor-made sensor molecules can be used e.g. where a screening with a protein against a protein library is performed for assumed protein-protein interaction, an antibody is an obvious choice. Both monoclonal and polyclonal antibodies may be used. As shown in Fig. 4 A, magnetic particles 15 are indirectly bound to the target sample 11. In Fig. 4B, the target sample 11 molecules are directly labeled by magnetic nanoparticles 15.
In Fig. 4C, target sample 11 is labeled by labels 12. Such a labeled target sample 11 (e.g. biotynilated sample DNA) is selectively bound to binding sites 9. Sensor molecules 13 (e.g. streptadivin) labeled with magnetic nanoparticles 15 are able to selectively bind the labels 12 on the target sample 11. Again, the magnetic nanoparticles 15 are indirectly bound to the target sample 11.
In Fig. 4D, there is a target 11 and a target labeled with magnetic nanoparticles 15 present in the fluid or gas. In a competitive assay, the target with magnetic nanoparticles is able to selectively bind, if it reaches the binding site 9 earlier than the target reaches the binding site. The more target labeled with magnetic nanoparticles 15 has been bound, the less target was present in the fluid or gas.
According to the invention, the magnetic particles 15 are preferably superparamagnetic nanoparticles having a diameter less 1 μm, having an average magnetic moment m. With nanoparticles are meant particles having at least one dimension ranging between 1 nm and 250 nm, preferably between 3 nm and 100 nm, more preferred between 10 nm and 60 nm. They are attached to the probe element 7 on the substrate 3 of the biochip 1, either directly or indirectly, preferably by any of the methods illustrated in Figs. 4A, 4B or 4C or similar. The nanoparticles 15 are usually positioned randomly within a well defined area on the chip 1, the well defined area being a probe area 5. The probe area 5 has a width Wi and a length /. The areal density of the nanoparticles 15 is n (nanoparticles per m2). The areal density will in general be a function of time.
The probe area 5 can be a single long stripe. Instead of a single long stripe, also a certain number of shorter stripes next to each other can be used, so that the total area taken by a single probe 5 becomes squarer, more as shown in Fig. 3. As this does not affect the results on electronic sensitivity, only the case of a single long stripe shaped probe area 5 is further elaborated hereinafter.
The functioning of the biochip 1 is as follows. Each probe element 7 is provided with binding sites 9 of a certain type. Target sample 11 is presented to or passed over the probe element 7, and if the binding sites 9 and the target sample 11 match, they bind to each other. Subsequently, magnetic nanoparticles 15 are directly or indirectly coupled to the target sample 11, as illustrated in Figs. 4 A, 4B and 4C. The magnetic nanoparticles 15 allow to read out the information gathered by the biochip IThe nanoparticles are preferably superparamagnetic nanoparticles 15 according to the present invention. Superparamagnetic particles are ferromagnetic particles of which at zero applied magnetic field the time- averaged magnetisation is zero due to thermally induced magnetic moment reversals that are frequent on the time scale of the magnetisation measurement. The average reversal frequency is given by - KV v -= v0 exp—
where KV (with K the magnetic anisotropy energy density and the particle volume) is the energy barrier that has to be overcome, and v0 is the reversal attempt frequency (typical value: 109 s"1). In some embodiments of the present invention the superparamagnetic particles
15 are preferably magnetised perpendicular to the plane of the chip in order to read out the information gathered by the biochip 1. In other embodiments the nanoparticles are magnetised parallel to the plane of the chip.
A magnetoresistive (MR) sensor, for example a giant magnetoresistive (GMR), a tunnel magnetoresistive (TMR) or an anisotropic magnetoresistive (AMR) sensor is provided according to the present invention to read out the information gathered by the biochip 1, thus to read out the presence or absence of the particles and/or to determine or estimate an areal density of the magnetic nanoparticles 15 on the probe area 5.
In an AMR, GMR or TMR material, the electrical resistance changes when the magnetization direction of one or more layers changes as a result of the application of a magnetic field. GMR is the magnetoresistance for layered structures with conductor interlayers in between the switching magnetic layers and TMR is the magneto-resistance for layered structures comprising magnetic metallic electrode layers and a dielectric interlayer. In GMR technology, structures have been developed in which two very thin magnetic films are brought very close together. The first magnetic film is pinned, what means that its magnetic orientation is fixed, usually by holding it in close proximity to an exchange bias layer, a layer of antiferromagnetic material that fixes the first magnetic film's magnetic orientation. The second magnetic layer or free layer, has a free, variable magnetic orientation. Changes in the magnetic field, in the present case originating from changes in the magnetisation of the superparamagnetic particles 15, cause a rotation of the free magnetic layer's magnetic orientation, which in turn, increases or decreases resistance of the entire sensor structure. Low resistance generally occurs when the sensor and pinned layers are magnetically oriented in the same direction. Higher resistance occurs when the magnetic orientations of the sensor and pim ed films oppose each other. TMR can be observed in systems made of two ferromagnetic electrode layers separated by an isolating (tunnel) barrier. This barrier must be very thin, i.e., of the order of lnm. Only then, the electrons can tunnel through this barrier, an entirely quantum- mechanical transport process. Again, the magnetic alignment of one layer can be changed without affecting the other by making use of an exchange bias layer. Changes in the magnetic field, in the present case again originating from changes in the magnetisation of the superparamagnetic particles 15, cause a rotation of the sensor film's magnetic orientation, which in turn, increases or decreases resistance of the entire sensor structure. The AMR of ferromagnetic materials is the dependence of the resistance on the angle the current makes with the magnetisation direction. This phenomenon is due to an asymmetry in the electron scattering cross section of ferromagnet materials.
In what follows, embodiments with a GMR sensor are considered but the present invention is not limited thereto. In a first embodiment, illustrated in Fig. 5 A, the magnetoresistive sensor, e.g. a GMR sensor, comprises a first sensor element, e.g. a GMR element 17 and a second sensor element, e.g. a GMR element 19 integrated in the biochip substrate 3 at a distance d under the surface of the substrate 3. Each of those GMR elements 17, 19 comprises a pinned film with the same magnetisation direction, parallel or substantially parallel to the x-direction, and a free film or sensor film, the magnetisation direction of which is able to change due to an external magnetic field. In order to read out the biochip 1, the superparamagnetic nanoparticles 15 bound to it are magnetised by an external, uniform magnetic field perpendicular to the plane of the biochip 1. The use of the perpendicular magnetic field creates a net, average, magnetic fieldat the two sides of the stripe shaped area covered by the nanoparticles close to the sensor elements 17, 19. The probe areas overlap only with half of the GMR sensor stripes, so that the net average field in the sensor stripes created by the nanoparticles is largest along or near the central axis of the stripes. The magnetised nanoparticles 15 produce regions of opposite magnetic induction vectors in the plane of the underlying GMR films, as shown in Fig. 11, and the resulting magnetic field is detected by GMR sensor elements 17, 19. A co-ordinate system has been introduced in Fig. 3 and in
Figs. 5A and 5B, and according to that co-ordinate system, the probe element 7 and the GMR elements 17, 19 extend in the y direction over a length /. If the magnetoresistive sensor elements 17, 19 lie in the xy plane, the GMR sensor elements 17, 19 only detect the x- component of the magnetic field. The resulting magnetic field from the magnetised superparamagnetic particles 15 is detected by the first GMR element 17 and the second GMR element 19. Over the width W of probe element 7, the limited (non-infinite) spatial extent of the magnetic particles contributes to a net signal generated by the magnetic field in the plane of the GMR elements 17, 19. The magnetic particles at the edges of the probe element have no particles next to them on one side and therefore the magnetic field from these particles has a net in-plane field component in one direction within the sensor elements 17. 19. Particles which lie closer to the centre of a sensor 17, 19 will have their in-plane magnetic field neutralised to a certain extent by neighbouring particles on both sides. Thus all particles contribute to the signals generated in the sensor elements 17, 19. Although all nanoparticles make some contribution to the net field, the particles close to the probe element edges contribute more to the total magnetic field. Because a magnetic sensor element 17, 19 is most sensitive in the centre, the magnetic nanoparticles 15 at the edges of probe element 7 preferably are, in perpendicular projection, in the centre of the sensor elements 17, 19. The functioning of the sensor does not depend critically on the distance W between the GMR stripes, which can be chosen much larger than the diameter of the nanoparticles. As an example, the pinned films in the first GMR element 17 and the second GMR element 19 may both be oriented in the positive x-direction. In the example given in Fig. 5 A, the magnetisation direction of the free film or sensor film of the first GMR element 17 will also be in the positive x-direction, and the magnetisation direction of the free films of the second GMR element 19 will be in the negative x-direction. The magnetisation directions of the pinned film and of the free film of the first GMR element 17 being the same, the first GMR element 17 exhibits a low resistance. As the magnetisation directions of the pinned film and of the free film of the second GMR element 19 are inverse, the second GMR element 19 exhibits a high resistance. The responses of the first GMR element 17 and the second GMR element 19 to the magnetic field present due to the magnetisation of the nanoparticles are shown in Fig. 5C (a) and (b) respectively. As shown in these graphs the magnetic field is either in the parallel or antiparallel direction compared with the biasing of the GMR element depending upon where the nanoparticle is placed.
The external magnetisation of the nanoparticles 15 can be done in any way known to a person skilled in the art. In particular it can be done by means of two coils 30 with a ferromagnetic core 32, as shown in Fig. 6. By applying a current of about 10 mA, for example, a magnetic field is generated, which is perpendicular to the substrate, in order to magnetise and align the magnetic moments of the nanoparticles 15. If the centres of both coils 30 are positioned along one line perpendicular to the substrate 3, if the coil diameter is approximately equal to or larger than the distance between the coils, and if the currents through the two coils are equal the magnetic field applied is to a good approximation perpendicular to the substrate 3 over an area equal to the coil area,. It can be useful to create the option for varying the position ofthe coils such that a linear gradient of the magnetic field occurs at the probe area, by having a small (x.y.z) translation of one or both coils Alternatively, a gradient could be created by making use of a current difference.. It can also be useful to create the option for slightly varying the orientation of the coils with respect to the sample area, resulting in small, well controlled in-plane field component. By making use of the combination of a magnetic field and a field gradient the strength of the binding of the magnetic particle can be determined in different directions. Bad binding can be detected, because at a certain magnetic field the magnetic nanoparticles lose their binding and are no longer detected by the MR sensor elements as they move into the bulk, too far from the sensors to be detected. This is of special importance to proteins that are large, while the binding of DNA is more ore less on/off. By making use of a small and well controllled in- plane field component in the x-direction, a correction can be made for a possible undesired shift of the center of the R(H) curves of the zero-field position, that in the case of exchange biased GMR or TMR sensors would result from a residual magnetic coupling between the free and pinned layers.
In a second embodiment of a GMR sensor, illustrated in Fig. 5B, the surface of the probe area 5 has a buffer or isolation zone which prevents or reduces the effect of any nanoparticles accidentally in this zone from affecting the measurement. For example the surface of the semiconductor sensor element can be structured. The purpose of the structuring can be to move the particles so far from the sensors that they no longer influence the measurement. Such structuring can be done physically, for example by means of a step profile or, as shown in Fig. 5B, with a gradient profile, e.g. by etching the semiconductor materials of the sensing element using anisotropic or isotropic etching solutions, e.g. to form a well. Alternatively, the probe area can be surrounded by a trench, deep enough to isolate any nanopartciles from the sensors. Besides or in addition to such a physical structuring, the surface of the probe area 5 can also be chemically or biochemically structured, e.g. by providing binding sites on probe element 7 of the probe area 5, but not on the regions 8 of the probe area located next to the probe element 7. Repellent materials may be used for these buffer zones.
The sensor comprises thin film materials, in the example under reference GMR materials, but also other thin film materials such as AMR, TMR or other MR materials with substantially linear R(H) curves around H=0 are possible materials. The sensor is separated from the magnetic nanoparticles 15 by a separation layer 40, e.g. silicon dioxide, silicon nitride, or an organic material such as a resist or epoxy for example.
The magnetisation of the nanoparticles 15 is controlled by an external field applied perpendicular to the surface of the biochip 1 (i.e. along the z-axis). The sensor is now exposed to the magnetic field resulting from the nanoparticles 15, of which the (stripe- averaged) in-plane component is is particularly high below the sides of the probe region covered with the magnetic nanoparticles. The change of the resistance difference of the sensors 17, 19, upon the application of a perpendicular magnetic field, is used to measure the areal density of nanoparticles on the probe element. The areal density of the magnetic nanoparticles 15 on the lower surface, probe element 7a, is given by density σ\, and on the upper surface by density σ . The use of a recessed probe region (d2 ≠O in fig. 5B) reduces the sensitivity to magnetic beads that reside on the surface at positions outside the probe area, i.e. without being specifically bound to probe molecules. In order to reduce the possible contribution to the signal of of the volume density of nanoparticles in the fluid in the recessed region, an additional washing step can be applied, or particles can be pulled away from the sensor surface by the application of a magnetic field and a magnetic field gradient.
The areal particle density typically ranges between zero and 103 to 104 particles per μm2. In practice it is relatively easy to fabricate micrometer or sub-micrometer sized physical structures on surfaces, while it is much more difficult to fabricate high-quality biochemical surfaces with micrometer or submicrometer patterns.
In the second embodiment of the present invention, the sensor consists of a pair of sensor elements 17 and 19 in a configuration with respect to a probe area as shown in fig. 5B. The areal density of magnetic nanobeads is derived from the difference of the resistance changes of the two sensor elements 17 and 19 upon the application of a perpendicular magnetic field. As sensor element 17 and 19 are equally sensitive to the effects of an in-plane component of the external field or due to thermal drift, these unwanted effects are cancelled. A practical method for obtaining the signal is to use sensors 17 and 19 as elements a and b in a Wlieatstone bridge, as shown schematically in fig. 7, in which the elements c and d are taken to be either (approximately) equal non-magnetic resistors, or magnetoresistors of the same type as sensors a and b, for which the resistance does not change in the applied field. This can be accomplished e.g. by applying no probe molecules close to sensors c and d or by, applying probe molecules above c and d sensors to a region that is much wider than the total width of the c and d sensor area (so that the net effect of all the dipolar fields is zero), or by locally applying a thick cover layer on top of sensors c and d so that the sensitivity to the presence of magnetic particles is strongly reduced. It is not necessary that the sensors c and d have the same physical dimensions as sensors a and b. Irrespective of the detailed practical method used for obtaining the signal we will call such a system a half- Wheatstone bridge.
It is advanteously when the sensor elements 17 and 19 and nominally identical sensor elements 17' and 19' form a full Wheatstone bridge, as shown in fig. 8. Here the elements 17, 19, 17' and 19' correspond to the elements a, b, d and c in the schematic structure shown in fig. 7. For a fixed sense current Isens the signal from which the areal partical density is obtained from the voltage meter measured as shown in fig. 8. A practical implementation of such a combination is schematically shown in Fig. 12, where a sequence of recessed regions 50 can be seen. The advantages of using differential measurements between two sensor elements 17, 19 for one probe element or between sets of sensors 17, 19 is that reference sensor elements are not required and a high detection sensitivity is obtained while maintaining independence from outside influences such as temperature. The sensitivity of a full Wheatstone bridge is twice the sensitivity of an otherwise identical half Wheatstone bridge. The output of the comparator provides for example an indication of whether nanoparticles are present (when it exceeds a minimum threshold) or can be used to determine or estimate the areal density of the particles.
For stripe shaped GMR and TMR sensor materials comprising pinned and free magnetic layers a substantially linear and hysteresis free resistance versus field curve can be obtained by making use of a magnetic confuguration for which the exchange bias direction is perpendicular to the length direction (current direction), and for which the easy magnetization direction of the free layer is parallel to the length direction. The external field to which the sensor is sensitive is directed perpendicular to the stripe length direction. The field range ('switch field') in which the magnetization of the free layer rotates from a direction parallel to a direction antiparallel to the direction of the 'pinned' exchange biased layer is determined by the combination of various contributions to the magnetic anisotropy, including an intrinsic contribution that can e.g. be due to growth in a magnetic field, and including the shape anisotropy. This is a so- called crossed anisotropy. In order to obtain a substantially linear R(H) curve around zero applied field the effective magnetic coupling field that acts on the free layer due to the presence of the pinned layer should be reduced to a value well below the switch field. There are different contributions to this coupling. The coupling due to pinholes in the interlayer, the interlayer exchange coupling, and the magnetostatic coupling due to non-flat magnetic metal/interlayer interfaces can be reduced by making use of interlayers that are sufficiently thick. The magnetostatic coupling related to the finite stripe width can e.g. be reduced by adapting the thicknesses of the free and pinned layer, or by making use of other that effectively reduce their magnetization times layer thickness product. It is also possible to reduce not these seperate contribitions to the coupling field, but to reduce the sum of all coupling contributions by designing a system in which the various contributions have opposite signs.
Well-known methods that lead to linear R(H) curves around zero field for AMR materials are the so-called soft-adjacent layer method and the barber-pole method. Both methods lead effectively to a configuration in which the angle between the current and the magnetization is close to 45° for H=0. A first example of a suitable GMR structure 60 for a sensor device according to the present invention is as shown in Fig. 9A. The GMR structure 60 comprises a thermally oxidised Silicon substrate 61 having a major surface 62. On the major surface 62 of the substrate 61, a stack of layers is applied being first a (plurality of) buffer layer(s) 63, an antiferromagnet (AF) 64, a pinned ferromagnet (Fpinned) 65, a non-magnetic material (NM) 66, a free ferromagnet (Ffree) 67 and a cover layer 68. 56, 66 and 67 are all metals. In particular, for this first example, each of the mentioned layers may consist of the following materials and thicknesses:
- for the buffer layer 63: a 3 nm thick Ta layer 63 a with on top thereof a 3 nm thick Ni80Fe20 layer 63b, - for the AF 64: a 10 nm thick hr20Mn8o layer,
- for the Fpinned layer 65: a 6 nm thick Co layer,
- for the NM layer 66: a 3 nm Cu layer,
- for the Ffi-ee layer 67: a 6 nm thick Ni8oFe20 layer, and
- for the cover layer 68: a 3 nm thick Ta layer. The Ir20Mn80 layer 64 is an antiferromagnet (AF) which causes the magnetisation of the Co layer 65 to be pinned in a direction perpendicular to the length as of the GMR stripes 17, 19. This is done by growing the Co layer 65 in a magnetic field, or by cooling the system, after growing, in a magnetic field from a temperature above the so-called 'blocking temperature' (which is for the materials under consideration about 300° C). The Cu layer 66 separates the pinned Co layer 65 from the free Ni80Fe20 layer 67. The upper Ta layer 68 protects the GMR structure 60 against oxidation when the wafer is exposed to air after deposition. The lower Ta layer 63 a and the abutting Ni80Fe20 layer 63b aid in building or growing a suitable microstructure and crystal orientation. A second example of a suitable GMR structure 69 is shown in Fig. 9B. The GMR structure 69 comprises a thermally oxidised Silicon substrate 61 having a major surface 62. On the major surface 62 of the substrate 61, a stack of layers is applied being first a (plurality of) buffer layer(s) 63, then an artificial antiferromagnet (AAF) 70, anon-magnetic material (NM) 66, a free ferromagnet (Ffree) 67 and a cover layer 68. In particular, for this second example, each of the mentioned layers may consist of the following materials and thicknesses:
- for the buffer layer 63: a 3 nm thick Ta layer 63a with on top thereof a 3 nm thick Ni80Fe20 layer 63b, - for the AAF 70: an AF layer, e.g. a 10 nm thick Ir20Mn80 layer 70a, a 6 nm thick Co layer 70b, a 0.8 nm Ru layer 70c and a 6 nm Co layer 70d,
- for the NM layer 66: a 3 nm Cu layer,
- for the Ffree layer 67: a 6 nm thick Ni80Fe o layer, and
- for the cover layer 68: a 3 nm thick Ta layer. The AAF layer 70 has the form of AF/Co/Ru/Co. The thickness of the Ru layer 70c is chosen so as to cause the magnetisation directions of the two Co layers 70b, 70d to be antiparallel due to exchange coupling over the Ru layer 70c. The AF layer 70a causes the magnetisations of the two Co layers 70b, 70d to be perpendicular to the length axis of the GMR stripes 17, 19. This second GMR structure 69 has as advantage over the first GMR structure
60 that the magnetic structure is more stable with regard to external magnetic fields. Furthermore, due to the thickness ratio between the two Co layers 70b, 70d which are separated by the Ru layer 70c, an adjustable coupling between the pinned layer 70d and the free layer 67 can be chosen. This can compensate for a small coupling over the Cu layer 66 between the pinned layer 70d and the free layer 67. The sum of all couplings is chosen to be essentially zero, so that at zero applied field (no particles) the magnetisation of the free layer 67 is exactly perpendicular to the one of the pinned layer 70d (and thus parallel to the axis of the stripe 17, 19). The thinner the Cu layer 66, the larger the magnetoresistance, but also the larger the parallel coupling between the free and pinned layers 65 and 67 (or 70d and 67).(for thicknesses as from 3 nm). With the magnetostatic field from the AAF 70, of which the sign and size can be varied by varying by the difference of the thicknesses of the layers 70b and 70d, it is possible to correct for this, what leads to more sensitivity of the MR sensor device. The diameter of the nanoparticles 15 (not shown in Fig. 3) is much smaller than W. With much smaller is meant at least a factor 10, preferably a factor 100 or more smaller.
There are three modes of operation, each of which is a separate embodiment of the present invention:
- Measurement of the resistance change uponapplication of a magnetic fieldperpendicular to the plane of the sensor elements. Three possible embodiments have already given above: measurement by using a separate element, by differential comparison of the outputs of sensor elements 17, 19 (half Wheatstone bridge), or by using a full Wheatstone bridge (see above).
- Measurement of the magnetisation after the magnetic field has been switched off. In this case, the field that is measured by sensor elements 17, 19 is due to the slow decay (thermal relaxation) of the magnetisation of those particles that are bound to the probe. The decay of the magnetisation from unbound particles is much faster, due to their fast random rotational motion. Soon after switching off the applied field, their net magnetisation is therefore negligible. Differential comparison detection (half and full Wheatstone bridge) can also be used in this mode.
- Measurement of the magnetisation after an in-plane magnetic field has been switched off. This is a less preferred embodiment. In-plane magnetisation causes an in-plane magnetic field in the sensor elements 17, 19. This in-plane magnetic field is however, not as strong as the magnetic field close to the ends of the magnetic dipoles and therefore the sensitivity of this technique is lower. The magnetic field from the nanoparticles that is measured is also due to the slow decay (thermal relaxation) of the magnetisation of those particles that are bound to the probe. The decay of the magnetisation from unbound particles is also much faster, due to their fast random rotational motion. Soon after switching off the applied field, their net magnetisation is therefore negligible. However, in this mode the outputs from the two sensors 17, 19 are almost identical so that instead of using two sensors a single centrally placed sensor element may be used. In a half- Wheatstone bridge the resistance change of this sensor may be compared to that of a nominally identical (reference) sensor under an area on the chip at which no probe molecules, and hence no beads, are present. Similarly, a full Wheatstone bridge can be created by using a and d sensors that are situated below a probe region, and b and c sensors that are situated under an area on the chip at which there are no probe molecules. In the present invention, all these modes are considered. In order to be able to provide all three modes with one device the sensor device may be equipped with means for generating either a magnetic field perpendicular to the plane of the probe element (modes 1 and 2) or a magnetic field parallel to the plane of the probe element in the plane of the nanoparticles (mode 3) or optionally both when desired. Similarly, switches may be provided to be able to measure the resistances of the sensor stripes separately, or e.g. to be able to measure sums or differences of resistances.
The required magnetic properties of the superparamagnetic particles 15, more specifically their relaxation time distribution, are different for the different modes, as discussed below.
The effect on the GMR signal due to the randomness of the positions of the nanoparticles 15 averages out when the probe element 7 is long enough in the y direction and the particle density n is large enough. A typical design may have a probe element 7 with length / = 1 mm in the y direction, and with width W= 3 in the x direction. The width w of each GMR element 17, 19 may be w = 3 μm , of which about half in the x direction is located under the probe element 7. If the total width W occupied by a probe area 5, is given by the width W of each probe element 7, half of the width of each of the two GMR elements 17, 19, plus a margin in order to eliminate cross-field effects, and that margin is taken 5 μm, there is sufficient space on a biochip 1 of 1 x 1 mm2 for 100 probe areas 5 next to each other. The stripe-averaged field in case of a lot of particles per unit area, for nanoparticles 15 with magnetisation along the positive z-axis, is indicated schematically by the field lines in Figs. 5 A and 5B. It is equal to a magnetic field due to two parallel current wires at the edges of the stripes, with a current
I = fflx/. . (eq. 1) Obviously, the moments m per superparamagnetic particle 15 should be as large as possible for a given volume of the particle 15, in order to obtain a magnetic field which is as large as possible.
The GMR elements 17, 19 probe the x-component of the magnetic field, which is positive for the first GMR element 17 and negative for the second GMR element 19. If the origin of the coordinate system is taken in the middle of the first GMR element 17, then the average x-component of the field in that element 17
. ---. 1 i 1 i w r r . , m ..- xx nn xx d a 2 A mm xx nn ww ιs: Hx av =- dx— — = x arctan — (eq. 2) x'av 2π w _ /2 x2 + d2 2π w 2d Therefore HXιav can be increased by making the width w of the GMR elements 17, 19 small, and the depth d of the GMR elements 17, 19 under the substrate surface smaller than or approximately equal to w. Making the width Wof the probe element 7 small does not change the field sensed at each of the GMR elements 17, 19, as long as the width Wof the probe element 7 is approximately equal to the width w of the GMR elements 17, 19 and the depth d of the GMR elements 17, 19 under the substrate surface, or larger. The field due to the nanoparticles 15 on the middle of the probe element 7 is then not detected. Otherwise, the signal will decrease with decreasing width of the probe element 7. So it is not usually advantageous to make the width W of the probe element 7 much larger than the width w of the GMR elements 17, 19, unless maybe for practical reasons such as patterning technology. The pair of GMR elements 17, 19 in which the signal is opposite can be used to make a Wheatstone bridge configuration in which all parts are magnetically equal, that is in which there are equal exchange bias directions in all branches. An example of such a Wheatstone bridge is given in Fig. 8. The signal doubles, due to the elimination of a non- active reference MR element, and a common mode signal (e.g. due to in-plane external fields or due to thermal drift) is cancelled.
The signal voltage is given by: ΔR^ H.
V ' S, = 2 x 1 sense x A ^^R = 2x I sense x
R ΔH„-. w wherein Isense is the sense current, Rsheet is the GMR sheet resistance,
(AR^ is the magnetoresistance ratio when the full dynamic range is used,
R and
(ΔH)max is the field range in which the element switches completely. If shape anisotropy determines this range,
(AH)mm = 2x -Msal , (eq. 4) w where t and Msat are the thickness and saturation magnetisation of the free magnetic layer, respectively.
Combining (eq. 1) - (eq. 4) leads to:
χ Rslιeet
Figure imgf000021_0001
The electronic noise is assumed to be due to thermal noise. The r.m.s. thermal noise voltage is:
VN = 4kTRAf
Figure imgf000022_0001
where the effective measurement time tmeas is equal to the time during which the signal is measured, provided that just before the measurement the magnetisation can be assumed to be zero (because the particles are superparamagnetic). That defines a reference level. The signal to noise ration is equal to SNR = VS/VN-
For proper functioning of the system, for the first mode (measurement of the magnetisation during application of the field) it is preferred that the superparamagnetic relaxation time of all particles is much smaller, at least a factor 5 smaller, preferably a factor 10 or more smaller, than the period of time during which the field is applied and during which the measurement is carried out. The magnetisation of the particles is then switched on and off almost instantaneously upon switching the field on and off. In that case, the magnetic dipolar interaction between the particles after a measurement is negligible, and the binding reaction can proceed without being disturbed by such interactions in between the measurements. This requires that the magnetic particles in the nanobeads should have a product of the volume V and the magnetic anisotropy constant K that is sufficiently small, hi this first mode of operation, the particles 15 that are not bound to the chip 1 should not be present at the chip interface during a measurement. This can be accomplished by a washing step just before each measurement, or by temporarily displacing the non-bound particles away from the chip 1 just after the application of a field plus a field gradient parallel to the normal direction. The resulting force should be sufficient for displacing the particles a few micrometers above the chip surface (where their dipolar field at the surface is small, and where their positions with respect to the GMR elements 17, 19 is sufficiently random, so that also for this reason the net signal is negligible). On the other hand, the force should be less than the force required for breaking a bond.
In the second (and third) modes of operation (measurement of the magnetisation after the field has been switched off), a field is first applied during a period t and after switching off the field, j? measurements of the decaying signal are carried out during a period p x tme s ∞ tf- Ideally, just after the magnetising field is switched off, all superparamagnetic particles 15 should be fully magnetised, but after the sequence ofp measurements has been carried out, all particles 15 should have lost their magnetisation. Otherwise, the particles 15 would interact magnetically during the reaction periods in between measurement periods. This would imply that only particles 15 can be used for which the relaxation time is less than tp By the application of applied fields with alternating signs in successive measurement cycles, one can prevent that a small unwanted fraction of bound particles 15 with a relaxation time that is larger than tf builds up a total magnetic moment that increases monotonically with the number of completed measurement cycles, and that does not decay to zero in between the periods during which the field is applied. On the other hand, the relaxation time should be larger than tmeas because otherwise even the first measurement after switching off the field would not yield a signal.
Practically, the above would imply that the relaxation time should be between 1 ms and 1 s (see below). This is a more difficult requirement than for the first mode of operation. Particles that fall outside this range do not contribute to the signal, and should ideally not be present. The particle diameter should therefore be to a very good approximation monodisperse. A method for creating such particles is known, and is described in S. Sun et al., "Monodisperse FePt Nanoparticles and Ferromagnetic Nanocrystal Superlattices", Science 287, 1989-1992 (2000).
The SNR is calculated for a system as specified by the table below, giving the system parameters for the example, for 35 nm commercially available magnetic particles, such as magnetite (Fe O4) particles.
Figure imgf000024_0001
The moment m indicated is the saturation moment, which is already obtained when the applied field is higher than 1.2 kA/m. The voltage over each MR element is 10 N. The power during a measurement, per probe, is 20 mW. The numerical results are as follows:
Vs =8.8x10 -16 II [v] vN=ι.3χ Λ:β-'xJ V eas-l
SNR = 6.8x10~sxnxJt,_
If it is assumed that the minimum SΝR required for the detection of the nanoparticles 15 is 10 (20 dB), then the minimum detectable areal density of nanoparticles, nmin, is 1.5xl08
"mm — [particles/m ]
<fi« The minimum number of detectable particles on a probe area of 10"8 m2 (100 μm x l00 μm) is
Figure imgf000025_0001
The above theory breaks down if the absolute number of particles per probe area is too small. A lower limit may be 50. This implies that increasing the measurement time tmeas will lead to a decrease of the minimum detectable number of nanoparticles, until tmeas is of the order of 1 ms. Fortunately, this measurement time is well below the targeted repeat time of the measurements (100 measurements over 3 minutes). It is not useful to use a larger measurement time. It is therefore concluded that, for the parameters used, and when tmeas > 1 ms, the minimum number of particles that can be measured with accuracy, 50 on a probe area, is determined by the statistics and not by the sensitivity of the GMR sensor.
The maximum measurable areal density of particles is equal to the lowest of the following two densities:
The density above which the magnetic dipolar interaction between the particles, or steric hindrance, becomes too strong. For 35 nm particles this may be at a density of the order of 100 particles per μm2.
The density above which the field from the particles saturates the GMR sensor. In the continuum approximation used this happens if Hx>av > H2AHsat, i.e. at a density of the order of approximately 960 particles per μm2. Neither of the two densities depends on the measurement time tmeas. In the case of the example given, the interparticle interaction, and not the GMR saturation field, will normally determine the maximum measurable number of particles.
The time averaged power dissipation is 2 mW for the first mode of operation, assuming 100 probes and a duty cycle of 1 : 1000 for each probe (one measurement per second, with a duration of 1 ms). Similarly, for the second mode of operation, the power dissipation isp x 2 mW, where ? is the number of 1 ms measurement intervals per cycle.
For the second mode of operation, 1/f noise may become important, especially if the period over which the decay of the signal is measured becomes as long as 1 s.
The above results can be generalised as follows. The areal density of particles that can be detected should not be below the density rc-(stat) that corresponds to the statistically determined value of «50 particles per probe, below which the above theory breaks down. For probes with an area equal to 104 μm2, n-(stat) = 0.005/μm2. The areal density of particles that can be measured is certainly lower than the density w+(int) at which interparticle interactions or steric hindrance become too large. It is assumed that «+(int) « 1.25 x 105/d2, d being the particle diameter in nm. So, independent of the sensitivity of the GMR elements used, the measurement time and the magnetic moments of the particles, the highest possible width of the dynamic range is:
2 x l07 max. dynamic range « — . d From this point of view, the use of small particles is advantageous, as it increases the width of the dynamic range. However, the actual lower limit of the density may not be given by π-(stat), but by a value n.(sens) = nmin that depends on the sensitivity of the GMR sensor. This is the case if «-(sens) > «_(stat). The value of w-(sens) is inversely proportional to the particle volume and to the squareroot of the measurement time. In addition, the actual upper limit of the density is not given by «+(int) but by the density «+(satur) at which the GMR element saturates, if w+(satur) < n+(int)_ For the conditions assumed, «+(satur) = 4.11 x 107/ 3.
Fig. 10 is a graph showing areal density (in particles/μm2) as a function of theparticle diameter (in nm). From the diagram the dynamic range can be derived for the system considered, as a function of the magnetic particle diameter, for the parameter values given in the table above, and for a measurement time of 1 ms. The upper limits of the dynamic range are given for higher particle diameters by n+(satur), which is due to saturation of the magnetoresistive element, and for lower particle diameters by n+(int), which is due to interparticle interactions or steric hindrance. The lower limits of the dynamic range are given for higher particle diameters by n-(stat), which is due to the statistical (random) position of the particles on the probe area, and for lower particle diameters by n-(sens), which is due to sensitivity of the magnetoresistive element. The overall upper sensitivity limit is given by line 30, and the overall lower sensitivity limit is given by line 31. The dynamic range for 35 nm particles is given by the double arrow 32. It can be seen from Fig. 10 that, for the measurement time of 1 ms assumed, the particle radius of 35 nm is optimal. A decrease of the MR element saturation field or an increase of the particle magnetisation lead to parallel downward shifts of the n.(sens) and n+(satur) lines. Separately or in combination, these two improvements of the system could shift the optimal diameter to at best approximately 10 nm, leading to a dynamic range of 2 x 105.
It is to be remarked that it has been assumed for reasons of simplicity that the magnetising field will be able to fully magnetise the particles. For a maximum magnetising field of 115 kA/m, this assumption breaks down when the particle radius is below approximately 10 nm. The actual values of ra-(sens) line are then higher than is indicated in Fig. 10.
While the invention has been shown and described with reference to preferred embodiments, it will be understood by those skilled in the art that various changes or modifications in form and detail may be made without departing from the scope and spirit of this invention.

Claims

CLAIMS:
1. Magnetoresistive sensor device for determining the presence or an areal density of magnetic nanoparticles (15) being directly or indirectly coupled to the target (11), the magnetoresistive sensor device comprising a substrate (3) having attached thereto a binding site (9) able to selectively bind a target (11), and a magnetoresistive sensor for detecting the magnetic field of magnetic nanoparticles (15) at least when coupled to the target, wherein the magnetoresistive sensor comprises pairs of first and second magnetoresistive sensing elements (17, 19) or first and second groups of magnetoresistive sensing elements, each pair being associated with and located parallel with a probe element having at least one binding site, the outputs of the first and second magnetoresistive elements or first and second groups of magnetoresistive sensing elements being fed to a comparator circuit.
2. Magnetoresistive sensor device according to claim 1, further comprising means for generating a magnetic field perpendicular to the magnetoresistive sensing elements.
3. Magnetoresistive sensor device according to Claim 1, wherein there is a probe area (5) present having at least one probe element (7) and there is an overlapping area between the magnetoresistive sensing elements (17, 19) and the probe area (5), seen in substantially perpendicular proj ection.
4. Magnetoresistive sensor device according to claim 1, further comprising means for generating a magnetic field parallel to the magnetoresistive sensing elements.
5. Magnetoresistive sensor device according to claims any of the previous claims, wherein the width and length dimensions of sensing elements are at least a factor 10 or more, preferably a factor 100 or more larger than the average diameter of the nanoparticles (15).
6. Magnetoresistive sensor device, according to any previous wherein the device is a microarray.
7. Magnetoresistive sensor device according to any previous claim, wherein the plurality of magnetoresistive sensing elements (17, 19) are giant magnetoresistive (GMR) elements.
8. Magnetoresistive sensor device according to any of claims 1 to 7, wherein the plurality of magnetoresistive sensing elements are tunnel magnetoresistive (TMR) elements.
9. Magnetoresistive sensor device according to any of claims 1 to 7, wherein the plurality of magnetoresistive sensing elements are anisotropic magnetoresistive (AMR) elements.
10. Magnetoresistive sensor device according to any of the 1, 2 and 7 to 9, wherein a pair of magnetoresistive sensing elements form a Wheatstone bridge or a half- Wheatstone bridge.
11. Magnetoresistive sensor device according to any previous claim, wherein each sensor of a pair of first and second magnetoresistive sensing elements (17, 19) or groups of first and second magnetoresistive sensing elements is biased in the same direction.
12. Magnetoresistive sensor device according to Claim 1, 10, wherein each magnetoresistive sensing element comprises a strip of magnetoresistive material, the magnetoresistive material having a linear resistance versus magnetic field curve and being substantially free of hysteresis.
13. Magnetoresistive sensor device according to claim 1, wherein the comparator circuit is integrated with a further electronic circuit being present in the substrate.
14. Magnetoresistive sensor device according to claim 12, wherein the width of the magnetoresistive sensing elements (17, 19) is at least 50%, preferably at least 60%, most preferred at least 70% of the width of the probe element (7).
15. Magnetoresistive sensor device according to claim 12, wherein the distance of the magnetoresistive sensing elements (17, 19) to the probe element 7, is smaller than the width of the magnetoresistive sensing elements.
16. Magnetoresistive sensor device according to any of the previous claims, wherein the magnetic nanoparticles (15) are superparamagnetic.
17. Magnetoresistive sensor device according to any of the previous claims, wherein the sensor device has a structured surface.
18. Magnetoresistive sensor device according to claim 17, wherein the structured surface has a step profile.
19. Magnetoresistive sensor device according to claim 17, wherein the structured surface has a gradient profile.
20. Magnetoresistive sensor according to any of claims 17 to 19, wherein the structured surface is a chemically structured surface.
21. Magnetoresistive sensor according to claim 20, wherein the chemically structured surface is obtained by having binding sites on part of the surface only.
22. A method for determining the presence or for measuring an areal density of magnetic nanoparticles on a substrate, comprising the steps of: - binding a target (11) to selective binding sites (9) on the substrate, the target sample (11) being directly or indirectly labeled with magnetic nanoparticles (15),
- sensing the presence of the bound magnetic nanoparticles (15) to a binding site to thereby determine the presence or density of the target (11) labeled with magnetic nanoparticles - wherein the sensing step is carried out by extracting two signals derived from the magnetic field generated by nanoparticles bound to the one binding site using magnetoresistive sensors elements; and
- determining the difference between the two signals.
23. The method according to claim 22, wherein a magnetic field is applied perpendicular to the magnetoresistive sensing elements.
24. The method according to claim 22, wherein a magnetic field is applied parallel to the magnetoresistive sensing elements.
25. A method according to any of the claims 22 to 24, wherein the sensing step is carried out by means of a magnetoresistive sensor comprising a plurality of giant magnetoresistive (GMR) sensing elements.
26. A method according to any of the claims 22 to 24, wherein the sensing step is carried out by means of a magnetoresistive sensor comprising a plurality of tunnel magnetoresistive (TMR) sensing elements.
27. A method according to any of the claims 22 to 24, wherein the sensing step is carried out by means of a magnetoresistive sensor comprising a plurality of anisotropic magnetoresistive (AMR) sensing elements.
28. A method according to any of claims 22, 25 to 27, wherein the sensing step is carried out by means of a Wheatstone bridge or a half- Wheatstone bridge.
29. A method according to any of claims 22 to 28, wherein the binding and sensing steps are carried out at a plurality of probe elements (7) on the micro-array (1).
30. A method according to any of claims 22 to 29, wherein the magnetic nanoparticles are superparamagnetic.
31. A method of detecting a target in a fluid, comprising the steps of:
- binding a target (11) to selective binding sites (9) on a substrate, the target sample (11) being directly or indirectly labeled with magnetic nanoparticles (15),
- sensing the presence of the bound magnetic nanoparticles (15) to a binding site to thereby determine the presence or density of the target (11) labeled with magnetic nanoparticles - wherein the sensing step is carried out by extracting two signals derived from the magnetic field generated by nanoparticles bound to the one binding site using magnetoresistive sensors elements; and
- determining the difference between the two signals.
32. A method as claimed in Claim 31 , wherein the fluid is blood.
33. A method as claimed in Claim 31, wherein the fluid is urine.
34. A system comprising the magnetoresistive sensor device as claimed in anyone of the claims 1-21, wherein the system is a blood tester.
35. A method for detecting a selected type of monecules in a fluid, whereby an agent containing nanoparticles is introduced in the fluid which agent chemically reacts with said selected type of molecules, thereby forming a target; and whereby the target is detected by a method according claim 31 to 33.
PCT/IB2002/005567 2001-12-21 2002-12-17 Sensor and method for measuring the areal density of magnetic nanoparticles on a micro-array WO2003054523A2 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP2003555187A JP2005513475A (en) 2001-12-21 2002-12-17 Sensor and method for measuring the area density of magnetic nanoparticles on a microarray
KR10-2004-7009884A KR20040068968A (en) 2001-12-21 2002-12-17 Sensor and method for measuring the areal density of magnetic nanoparticles on a micro-array
DE60211555T DE60211555T2 (en) 2001-12-21 2002-12-17 SENSOR AND METHOD FOR MEASURING THE FLAT DENSITY OF MAGNETIC NANOPARTICLES ON A MICROARRAY
EP02790607A EP1456658B1 (en) 2001-12-21 2002-12-17 Sensor and method for measuring the areal density of magnetic nanoparticles on a micro-array
US10/498,958 US7048890B2 (en) 2001-12-21 2002-12-17 Sensor and method for measuring the areal density of magnetic nanoparticles on a micro-array
AU2002366904A AU2002366904A1 (en) 2001-12-21 2002-12-17 Sensor and method for measuring the areal density of magnetic nanoparticles on a micro-array
US11/338,022 US20060128035A1 (en) 2001-12-21 2006-01-24 Sensor and method for measuring the areal density of magnetic nanoparticles on a micro-array

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01205152.0 2001-12-21
EP01205152 2001-12-21

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/338,022 Division US20060128035A1 (en) 2001-12-21 2006-01-24 Sensor and method for measuring the areal density of magnetic nanoparticles on a micro-array

Publications (2)

Publication Number Publication Date
WO2003054523A2 true WO2003054523A2 (en) 2003-07-03
WO2003054523A3 WO2003054523A3 (en) 2004-03-18

Family

ID=8181541

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2002/005567 WO2003054523A2 (en) 2001-12-21 2002-12-17 Sensor and method for measuring the areal density of magnetic nanoparticles on a micro-array

Country Status (10)

Country Link
US (2) US7048890B2 (en)
EP (1) EP1456658B1 (en)
JP (1) JP2005513475A (en)
KR (1) KR20040068968A (en)
CN (1) CN100343670C (en)
AT (1) ATE326697T1 (en)
AU (1) AU2002366904A1 (en)
DE (1) DE60211555T2 (en)
TW (1) TWI295323B (en)
WO (1) WO2003054523A2 (en)

Cited By (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1469311A1 (en) * 2002-01-29 2004-10-20 Asahi Kasei Kabushiki Kaisha Biosensor, magnetic molecule measurement method, and measurement object measuring method
WO2005010543A1 (en) * 2003-07-30 2005-02-03 Koninklijke Philips Electronics N.V. On-chip magnetic sensor device with suppressed cross-talk
WO2005010503A1 (en) * 2003-07-30 2005-02-03 Koninklijke Philips Electronics N.V. Integrated 1/f noise removal method for a magneto-resistive nano-particle sensor
WO2005073695A1 (en) * 2004-01-26 2005-08-11 Koninklijke Philips Electronics N.V. Method and device for on-chip magnetic resonance spectroscopy
EP1566651A1 (en) * 2004-02-20 2005-08-24 TDK Corporation Magnetic sensing device, method of forming the same, magnetic sensor and ammeter
WO2005111596A1 (en) * 2004-05-18 2005-11-24 Koninklijke Philips Electronics N.V. Magnetic rotation to improve signal-over-background in biosensing
WO2005111614A1 (en) * 2004-05-17 2005-11-24 Randox Laboratories Limited Magnetic particle detector system and method of performing binding assay
WO2005111615A1 (en) * 2004-05-17 2005-11-24 Randox Laboratories Limited Magnetic particle detector system
WO2005116661A1 (en) * 2004-05-24 2005-12-08 Koninklijke Philips Electronics N.V. Magneto-resistive sensor for high sensitivity depth probing
WO2006018811A1 (en) * 2004-08-20 2006-02-23 Instituto De Engenharia De Sistemas E Computadores Para Os Microsistemas E As Nanotecnologias (Inesc-Mn) A bio-electronic device
WO2006059268A2 (en) * 2004-11-30 2006-06-08 Koninklijke Philips Electronics N.V. A method for calibrating a transfer function of a magnetic sensor
WO2006080571A1 (en) * 2005-01-31 2006-08-03 Canon Kabushiki Kaisha Magnetic sensor
EP1687634A2 (en) * 2003-11-12 2006-08-09 The Board of Trustees of The Leland Stanford Junior University Magnetic nanoparticles, magnetic detector arrays, and methods for their use in detecting biological molecules
JP2006208295A (en) * 2005-01-31 2006-08-10 Canon Inc Magnetic sensor, detection method using it, target substance detecting sensor and target substance detecting kit
JP2006234762A (en) * 2005-02-28 2006-09-07 Asahi Kasei Corp Biosensor
WO2006134546A2 (en) * 2005-06-17 2006-12-21 Koninklijke Philips Electronics N.V. Accurate magnetic biosensor
JP2007500347A (en) * 2003-07-30 2007-01-11 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ On-chip magnetic particle sensor with improved SNR
WO2007010447A2 (en) * 2005-07-21 2007-01-25 Koninklijke Philips Electronics N. V. Microchip assembly with short-distance interaction
WO2006131892A3 (en) * 2005-06-09 2007-02-22 Koninkl Philips Electronics Nv Amplification of nucleic acids with magnetic detection
WO2007042959A2 (en) * 2005-10-12 2007-04-19 Koninklijke Philips Electronics N.V. Magnetic sensor device with different internal operating frequencies
WO2007106580A2 (en) * 2006-03-15 2007-09-20 Micronics, Inc. Rapid magnetic flow assays
WO2007129284A1 (en) 2006-05-10 2007-11-15 Koninklijke Philips Electronics N.V. System and methods for actuation on magnetoresistive sensors
WO2007132384A2 (en) 2006-05-09 2007-11-22 Koninklijke Philips Electronics N. V. Magnetic sensor device with field generators and sensors
WO2007132372A1 (en) * 2006-05-09 2007-11-22 Koninklijke Philips Electronics N. V. A magnetic sensor device for and a method of sensing magnetic particles
CN100360939C (en) * 2005-05-26 2008-01-09 上海交通大学 Method for detecting cancer cell by using probe of piezoelectric sensing chip controlled from biologic magnetic
WO2007132366A3 (en) * 2006-05-09 2008-03-27 Koninkl Philips Electronics Nv Microelectronic sensor device for concentration measurements
WO2008044174A1 (en) 2006-10-12 2008-04-17 Koninklijke Philips Electronics N.V. Magnetic and/or electric label assisted detection system and method
WO2008044162A3 (en) * 2006-10-09 2008-07-17 Koninkl Philips Electronics Nv Magnetic sensor device with pairs of detection units
JP2008528998A (en) * 2005-01-31 2008-07-31 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ Fast and sensitive biosensing
WO2008091364A2 (en) * 2006-06-30 2008-07-31 Intel Corporation Nanoparticles as tags for bioanalyte detection by nuclear magnetic resonance or electron spin resonance
WO2008102299A1 (en) * 2007-02-23 2008-08-28 Koninklijke Philips Electronics N.V. Magnetic sensor device with field generator and sensor element
FR2919390A1 (en) * 2007-07-27 2009-01-30 Bertin Technologies Soc Par Ac METHOD FOR ASSAYING AN ANALYTE IN A LIQUID MEDIUM
JP2009031303A (en) * 2008-09-22 2009-02-12 Canon Inc Detection device and kit for detection
EP2060637A1 (en) * 2007-11-14 2009-05-20 Koninklijke Philips Electronics N.V. Means and methods for detection of nucleic acids
WO2009081309A3 (en) * 2007-12-18 2009-08-20 Koninkl Philips Electronics Nv A magnetic sensor device
EP2009456A3 (en) * 2007-06-29 2010-10-06 The Boeing Company Radio frequency sensor systems, electromagnetic sensor arrays, and methods of manufacture
EP2246702A1 (en) * 2007-12-03 2010-11-03 Tokyo Institute of Technology Biosensing method using coated magnetic microparticles and biosensing device to be used in the method
WO2011001337A1 (en) * 2009-06-30 2011-01-06 Koninklijke Philips Electronics N. V. Magnetic sensor device, method of operating such a device and sample
DE102010040391A1 (en) * 2010-09-08 2012-03-08 Siemens Aktiengesellschaft Magnetic flow cytometry for single cell detection
WO2012049075A1 (en) * 2010-10-15 2012-04-19 International Business Machines Corporation Magnetic nanoparticle detection across a membrane
US8283183B2 (en) 2004-04-28 2012-10-09 Canon Kabushiki Kaisha Detecting method, detection device and detection kit
US8283912B2 (en) 2007-04-03 2012-10-09 Koninklijke Philips Electronics N.V. Sensor device with magnetic washing means
US8283184B2 (en) * 2005-09-21 2012-10-09 Siemens Aktiengesellschaft Method for measurement of very small local magnetic fields, in particular for measurement of local magnetic stray fields produced by magnetic beads, and an associated device for carrying out the method
US8323570B2 (en) 2006-03-21 2012-12-04 Koninklijke Philips Electronics N.V. Microelectronic sensor device with sensor array
DE102011080945A1 (en) * 2011-08-15 2013-02-21 Siemens Aktiengesellschaft Dynamic state determination of analytes by means of magnetic flow measurement
WO2013059692A1 (en) * 2011-10-19 2013-04-25 Regents Of The University Of Minnesota Magnetic biomedical sensors and sensing system for high-throughput biomolecule testing
US9151763B2 (en) 2011-03-09 2015-10-06 Magarray, Inc. Systems and methods for high-throughput detection of an analyte in a sample
US9272290B2 (en) 2009-07-17 2016-03-01 Koninklijke Philips N.V. Apparatus for the enrichment of magnetic particles
US9863939B2 (en) 2007-09-20 2018-01-09 Magarray, Inc. Analyte detection with magnetic sensors
US9895692B2 (en) 2010-01-29 2018-02-20 Micronics, Inc. Sample-to-answer microfluidic cartridge
WO2018052639A1 (en) * 2016-09-15 2018-03-22 Qualcomm Incorporated Magnetoresistive (mr) sensors employing dual mr devices for differential mr sensing
US9927431B2 (en) 2011-09-14 2018-03-27 Regents Of The University Of Minnesota External field—free magnetic biosensor
EP3167300A4 (en) * 2014-07-09 2018-04-11 Zepto Life Technology, LLC Method and system for substance detection with a magnetic sensor
US10065186B2 (en) 2012-12-21 2018-09-04 Micronics, Inc. Fluidic circuits and related manufacturing methods
US10087440B2 (en) 2013-05-07 2018-10-02 Micronics, Inc. Device for preparation and analysis of nucleic acids
US10190153B2 (en) 2013-05-07 2019-01-29 Micronics, Inc. Methods for preparation of nucleic acid-containing samples using clay minerals and alkaline solutions
US10267871B2 (en) 2013-03-15 2019-04-23 Magarray, Inc. Magnetic tunnel junction sensors and methods for using the same
US10386377B2 (en) 2013-05-07 2019-08-20 Micronics, Inc. Microfluidic devices and methods for performing serum separation and blood cross-matching
US10436713B2 (en) 2012-12-21 2019-10-08 Micronics, Inc. Portable fluorescence detection system and microassay cartridge
US10518262B2 (en) 2012-12-21 2019-12-31 Perkinelmer Health Sciences, Inc. Low elasticity films for microfluidic use
US10794903B2 (en) 2008-10-17 2020-10-06 Minicare B.V. Pulsed magnetic actuation for sensitive assays
WO2022269116A1 (en) * 2021-06-21 2022-12-29 Universidad Complutense De Madrid Sensor devices, electrical connection systems and methods for detecting genetic or biochemical material as disease biomarkers

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2520670A1 (en) * 2004-09-23 2006-03-23 National Research Council Of Canada Nanocrystal coated surfaces
US8456157B2 (en) * 2005-07-27 2013-06-04 University Of Houston Nanomagnetic detector array for biomolecular recognition
US8143073B2 (en) * 2005-08-12 2012-03-27 Siemens Aktiengesellschaft Apparatus for carrying out an analysis process, in particular for identification of biochemical molecules, and analysis processes which can be carried out using this apparatus
DE102006037739B4 (en) * 2005-08-12 2011-09-15 Siemens Ag Device for carrying out an analysis method, in particular for the detection of biochemical molecules, and analysis methods that can be carried out with this device
DE102006042044B4 (en) * 2005-09-21 2020-02-06 Siemens Aktiengesellschaft Method for measuring the smallest local magnetic fields, in particular for measuring local magnetic stray fields generated by magnetic beads, and associated device for carrying out the method
JP2009517651A (en) * 2005-11-25 2009-04-30 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ Magnetic biosensor for determining enzyme activity
DE102006003177A1 (en) * 2006-01-23 2007-08-02 Siemens Ag Apparatus and method for detecting an analyte
JP4837410B2 (en) * 2006-03-22 2011-12-14 富士フイルム株式会社 Target compound detection method
US8945946B2 (en) * 2006-03-31 2015-02-03 Canon Kabushiki Kaisha Sensor element and detection method of magnetic particles using this element, and detection method of target substance
DE102006016334B4 (en) * 2006-04-06 2018-11-15 Boehringer Ingelheim Vetmedica Gmbh Method and device for detecting magnetizable particles
FI121248B (en) * 2006-04-21 2010-08-31 Magnasense Technologies Oy Device for measuring magnetic particles and the corresponding method
US20090170212A1 (en) * 2006-05-10 2009-07-02 Koninklijke Philips Electronics N.V. Rapid magnetic biosensor
JP2009543039A (en) * 2006-06-28 2009-12-03 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ Magnetic sensor device having magnetic field generator and sensor element
EP2041593A2 (en) * 2006-07-11 2009-04-01 Koninklijke Philips Electronics N.V. Magnetic sensor device
US8133439B2 (en) * 2006-08-01 2012-03-13 Magic Technologies, Inc. GMR biosensor with enhanced sensitivity
US20100259250A1 (en) * 2006-08-09 2010-10-14 Koninklijke Philips Electronics N.V. Magnetic sensor device on a microchip
US8372344B2 (en) * 2006-10-11 2013-02-12 University Of South Carolina Nanoscale spintronic chemical sensor
EP2097751A4 (en) * 2006-10-30 2013-05-08 Stc Unm Magnetically susceptible particles and apparatuses for mixing the same
US8114683B2 (en) * 2007-03-05 2012-02-14 Headway Technologies, Inc. Low temperature method to enhance detection of magnetic beads
WO2008107827A1 (en) * 2007-03-06 2008-09-12 Koninklijke Philips Electronics N. V. An electromagnetic system for biosensors
EP1967855A1 (en) * 2007-03-08 2008-09-10 Koninklijke Philips Electronics N.V. Magnetic sensor device
DE102007015543A1 (en) * 2007-03-30 2008-10-09 Siemens Ag Method for detection of biological reaction products on sensor surfaces, involves moving beads into desired direction, particularly from berth to detected biologically active substances, where biological reaction products have Biotins
EP2017619A1 (en) * 2007-07-20 2009-01-21 Koninklijke Philips Electronics N.V. Magnetic sensor device
CN101802614B (en) * 2007-09-21 2013-08-07 皇家飞利浦电子股份有限公司 Sensor with high frequency AC magnetic field and method for describing flow sample feature
US9656271B2 (en) * 2007-12-04 2017-05-23 Headway Technologies, Inc. Guided transport of magnetically labeled biological molecules and cells
CN101889208A (en) * 2007-12-07 2010-11-17 皇家飞利浦电子股份有限公司 Magnetic washing for biosensor
KR100949804B1 (en) * 2007-12-14 2010-03-30 한국전자통신연구원 Magnetic field detection device
KR100952468B1 (en) * 2007-12-14 2010-04-13 한국전자통신연구원 Method of manufacturing magnetic field detection device
WO2009081310A1 (en) * 2007-12-20 2009-07-02 Koninklijke Philips Electronics N. V. Positioning of magnetic coils in a sensor device
EP2073016A1 (en) * 2007-12-20 2009-06-24 Koninklijke Philips Electronics N.V. Magnetic label based detection
CA2711956A1 (en) 2008-01-17 2009-07-23 The Regents Of The University Of California Integrated magnetic field generation and detection platform
EP2283351B1 (en) * 2008-05-14 2019-02-27 Koninklijke Philips N.V. Method and apparatus for measuring oxygen concentration using giant magnetoresistance
JP5567577B2 (en) * 2008-10-16 2014-08-06 コーニンクレッカ フィリップス エヌ ヴェ Method and apparatus for determining the amount of a magnetically labeled target component
CN102300800A (en) * 2008-11-03 2011-12-28 曳达研究和发展有限公司 Magnetic Patterning Method And System
KR101181697B1 (en) * 2008-12-22 2012-09-19 한국전자통신연구원 Cross type magnetic array sensors for biomolecules magnetic bead detection
US9121887B2 (en) * 2009-02-26 2015-09-01 Regents Of The University Of Minnesota High magnetic moment particle detection
US9599591B2 (en) 2009-03-06 2017-03-21 California Institute Of Technology Low cost, portable sensor for molecular assays
US8993236B2 (en) * 2009-04-17 2015-03-31 California Institute Of Technology Electromagnetic molecular sensors and methods of using same
CN102356329B (en) * 2009-03-10 2015-04-08 小利兰·斯坦福大学托管委员会 Temperature and drift compensation in magnetoresistive sensors
KR101034273B1 (en) * 2009-04-07 2011-05-16 최철원 Method Of And System For Microarray Anaysis Using Magnetic Bead
EP2419733A4 (en) * 2009-04-13 2013-12-25 Univ Leland Stanford Junior Methods and devices for detecting the presence of an analyte in a sample
KR101009802B1 (en) * 2009-05-11 2011-01-19 금오공과대학교 산학협력단 System and method for measurement of particle density
WO2010136440A1 (en) * 2009-05-25 2010-12-02 Insplorion Ab Sensor using localized surface plasmon resonance (lspr)
US20110076782A1 (en) * 2009-09-28 2011-03-31 International Business Machines Corporation Read-after-write detection of analytes via nanoparticle-labeled substances
JP5643825B2 (en) 2009-09-28 2014-12-17 コーニンクレッカ フィリップス エヌ ヴェ Substance determination device
JP5805651B2 (en) * 2009-11-06 2015-11-04 サイエンティフィック ナノメディスン, インコーポレイテッドScientific Nanomedicine, Inc. Detection, measurement, and imaging of cells and other biological materials such as cancer using target nanoparticles and their magnetic particles
JP5765907B2 (en) * 2009-11-09 2015-08-19 株式会社フェローテック Magnetic members and electronic parts
CN106198715B (en) * 2010-03-12 2020-01-10 小利兰·斯坦福大学托管委员会 Magnetic sensor based quantitative binding kinetics analysis
DE102010020784A1 (en) * 2010-05-18 2011-11-24 Siemens Aktiengesellschaft Method for detecting magnetically marked objects and corresponding device
KR101157997B1 (en) * 2010-08-19 2012-06-25 주식회사 엘지생명과학 System for signal detection of specimen using magnetic resistance sensor
GB201016484D0 (en) 2010-09-30 2010-11-17 Geneseque As Method
US20140099663A1 (en) * 2010-11-15 2014-04-10 Regents Of The University Of Minnesota Gmr sensor
CN102487118B (en) * 2010-12-05 2014-04-30 北京德锐磁星科技有限公司 Magnetic biosensor and preparation method thereof
US9304130B2 (en) * 2010-12-16 2016-04-05 International Business Machines Corporation Trenched sample assembly for detection of analytes with electromagnetic read-write heads
US9040311B2 (en) 2011-05-03 2015-05-26 International Business Machines Corporation Calibration assembly for aide in detection of analytes with electromagnetic read-write heads
US8855957B2 (en) 2011-05-03 2014-10-07 International Business Machines Corporation Method for calibrating read sensors of electromagnetic read-write heads
US9229071B2 (en) 2011-06-01 2016-01-05 International Business Machines Corporation Identification of molecules based on frequency responses using electromagnetic write-heads and magneto-resistive sensors
CN102393453B (en) * 2011-08-22 2013-09-18 中国科学院宁波材料技术与工程研究所 Magnetically-labeled biological sensor as well as production method and detection method thereof
PT2800970T (en) 2012-01-04 2016-12-27 Magnomics S A Monolithic device combining cmos with magnetoresistive sensors
US9435800B2 (en) 2012-09-14 2016-09-06 International Business Machines Corporation Sample assembly with an electromagnetic field to accelerate the bonding of target antigens and nanoparticles
US9767943B2 (en) 2013-11-07 2017-09-19 University Of South Carolina Patterned nanoparticle assembly methodology
CN106461741B (en) * 2014-01-31 2019-11-01 南澳大利亚大学 For detecting the sensor of magnetic particle
US9678169B2 (en) * 2014-07-09 2017-06-13 Voltafield Technology Corp. Testing assembly for testing magnetic sensor and method for testing magnetic sensor
GB201413929D0 (en) 2014-08-06 2014-09-17 Geneseque As Method
WO2016029943A1 (en) * 2014-08-27 2016-03-03 Siemens Aktiengesellschaft Method for determining at least one physiological parameter of a biological sample
CN105092879B (en) * 2015-08-06 2019-08-13 德惠市北方汽车底盘零部件有限公司 Composite electronic component
JP6812986B2 (en) * 2015-11-10 2021-01-13 Tdk株式会社 Sensors and biochips
CN109073597A (en) 2016-03-28 2018-12-21 Tdk株式会社 chemical sensor
CN108780067A (en) * 2016-03-28 2018-11-09 Tdk株式会社 biosensor and biochip
CN108885190B (en) * 2016-03-28 2022-06-24 Tdk株式会社 Biosensor and biochip
JP6668176B2 (en) * 2016-06-16 2020-03-18 株式会社東芝 Sensor
CN107796865B (en) 2016-09-05 2021-05-25 财团法人工业技术研究院 Biomolecular magnetic sensor
WO2018156920A1 (en) * 2017-02-24 2018-08-30 Nano Theranostics, Inc Doped magnetic nanoparticles
DE102017114537A1 (en) * 2017-06-29 2019-01-03 Endress+Hauser Conducta Gmbh+Co. Kg Sensor membrane, sensor cap and optical sensor
CN107394062B (en) * 2017-07-20 2019-02-05 京东方科技集团股份有限公司 A kind of organic LED display panel and preparation method thereof, display device
US10738342B2 (en) 2018-08-30 2020-08-11 Urinary Technologies, Inc. System for microbial species detection, quantification and antibiotic susceptibility identification
US10978376B2 (en) * 2019-01-18 2021-04-13 Electronics And Telecommunications Research Institute Sensing device and method for fabricating the same
EP3941625A1 (en) 2019-04-12 2022-01-26 Western Digital Technologies Inc. Nucleic acid sequencing by synthesis using magnetic sensor arrays
US11609208B2 (en) * 2019-04-12 2023-03-21 Western Digital Technologies, Inc. Devices and methods for molecule detection based on thermal stabilities of magnetic nanoparticles
US11112468B2 (en) * 2019-04-12 2021-09-07 Western Digital Technologies, Inc. Magnetoresistive sensor array for molecule detection and related detection schemes
CN110274951A (en) * 2019-05-20 2019-09-24 青岛大学 A kind of magnetic label and its detection system, detection method, preparation method
CN112082901B (en) * 2019-06-13 2022-02-22 宁德时代新能源科技股份有限公司 Surface density measurement compensation system
CN110302838B (en) * 2019-06-20 2022-04-15 苏州大学 Magnetic Fe with PNH surface modified2O3Nano-beads and their use in water treatment
JP7136137B2 (en) * 2020-01-29 2022-09-13 Tdk株式会社 Magnetic sensor, magnetic detection device and magnetic detection system
CN112924906B (en) * 2021-01-26 2022-04-05 西安交通大学 Wireless flexible magnetic sensor based on magnetocaloric effect, and preparation method and detection method thereof
CA3214597C (en) 2021-03-22 2024-04-23 NearField Atomics Inc. Systems and methods for measuring magnetic fields from solvated target molecules using a magnetoresistive sensor
US20230243778A1 (en) * 2022-01-28 2023-08-03 Western Digital Technologies, Inc. Self-aligned surface modification for magnetochemical sensors
WO2023208697A1 (en) * 2022-04-29 2023-11-02 Analog Devices International Unlimited Company Comparative measurement using particles within one or more compartments

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981297A (en) * 1997-02-05 1999-11-09 The United States Of America As Represented By The Secretary Of The Navy Biosensor using magnetically-detected label
WO2000026669A1 (en) * 1998-11-05 2000-05-11 Bio-Spectrum Technologies, Inc. System and method for biochemical assay
WO2000061803A1 (en) * 1999-04-13 2000-10-19 Nanogen, Inc. Magnetic bead-based array for genetic detection
WO2001014591A1 (en) * 1999-08-21 2001-03-01 Fox John S High sensitivity biomolecule detection with magnetic particles
WO2001057506A1 (en) * 2000-02-04 2001-08-09 The United States Of America As Represented By The Secretary Of The Navy High efficiency magnetic sensor for magnetic particles

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252459A (en) * 1988-09-23 1993-10-12 Abbott Laboratories Indicator reagents, diagnostic assays and test kits employing organic polymer latex particles
US5021736A (en) * 1989-09-19 1991-06-04 Texas Instruments Incorporated Speed/position sensor calibration method with angular adjustment of a magnetoresistive element
US5412087A (en) * 1992-04-24 1995-05-02 Affymax Technologies N.V. Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces
JPH06220609A (en) * 1992-07-31 1994-08-09 Sony Corp Magnetoresistance effect film, its production, magnetoresistance effect element using the film and magnetoresistance effect-type magnetic head
US5569544A (en) * 1992-11-16 1996-10-29 Nonvolatile Electronics, Incorporated Magnetoresistive structure comprising ferromagnetic thin films and intermediate layers of less than 30 angstroms formed of alloys having immiscible components
CN1076784A (en) * 1993-03-10 1993-09-29 北京放射医学研究所 Magnetic corpuscular immune separating agent and preparation
US5411814A (en) * 1994-01-26 1995-05-02 At&T Corp. Article comprising magnetoresistive oxide of La, Ca, Mn additionally containing either of both of Sr and Ba
US5739990A (en) * 1996-11-13 1998-04-14 Read-Rite Corporation Spin-valve GMR sensor with inbound exchange stabilization
US6743639B1 (en) * 1999-10-13 2004-06-01 Nve Corporation Magnetizable bead detector
US20040219695A1 (en) * 2002-01-19 2004-11-04 Fox John Stewart High sensitivity detection of and manipulation of biomolecules and cells with magnetic particles
EP1525447A4 (en) * 2002-05-31 2006-12-06 Univ California Method and apparatus for detecting substances of interest

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981297A (en) * 1997-02-05 1999-11-09 The United States Of America As Represented By The Secretary Of The Navy Biosensor using magnetically-detected label
WO2000026669A1 (en) * 1998-11-05 2000-05-11 Bio-Spectrum Technologies, Inc. System and method for biochemical assay
WO2000061803A1 (en) * 1999-04-13 2000-10-19 Nanogen, Inc. Magnetic bead-based array for genetic detection
WO2001014591A1 (en) * 1999-08-21 2001-03-01 Fox John S High sensitivity biomolecule detection with magnetic particles
WO2001057506A1 (en) * 2000-02-04 2001-08-09 The United States Of America As Represented By The Secretary Of The Navy High efficiency magnetic sensor for magnetic particles

Cited By (118)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1469311A4 (en) * 2002-01-29 2005-08-31 Asahi Chemical Ind Biosensor, magnetic molecule measurement method, and measurement object measuring method
EP1469311A1 (en) * 2002-01-29 2004-10-20 Asahi Kasei Kabushiki Kaisha Biosensor, magnetic molecule measurement method, and measurement object measuring method
WO2005010543A1 (en) * 2003-07-30 2005-02-03 Koninklijke Philips Electronics N.V. On-chip magnetic sensor device with suppressed cross-talk
WO2005010503A1 (en) * 2003-07-30 2005-02-03 Koninklijke Philips Electronics N.V. Integrated 1/f noise removal method for a magneto-resistive nano-particle sensor
JP2007500347A (en) * 2003-07-30 2007-01-11 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ On-chip magnetic particle sensor with improved SNR
JP2007514932A (en) * 2003-11-12 2007-06-07 ザ・ボード・オブ・トラスティーズ・オブ・ザ・レランド・スタンフォード・ジュニア・ユニバーシティ Magnetic nanoparticles, magnetic detector arrays, and methods for their use in the detection of biological molecules
US8318093B2 (en) 2003-11-12 2012-11-27 The Board Of Trustees Of The Leland Stanford Junior University Magnetic nanoparticles, magnetic detector arrays, and methods for their use in detecting biological molecules
US7682838B2 (en) 2003-11-12 2010-03-23 The Board Of Trustees Of The Leland Stanford Junior University Magnetic nanoparticles, magnetic detector arrays, and methods for their use in detecting biological molecules
EP1687634A2 (en) * 2003-11-12 2006-08-09 The Board of Trustees of The Leland Stanford Junior University Magnetic nanoparticles, magnetic detector arrays, and methods for their use in detecting biological molecules
US7906345B2 (en) * 2003-11-12 2011-03-15 The Board Of Trustees Of The Leland Stanford Junior University Magnetic nanoparticles, magnetic detector arrays, and methods for their use in detecting biological molecules
JP2013040951A (en) * 2003-11-12 2013-02-28 Board Of Trustees Of The Leland Stanford Junior Univ Magnetic nanoparticle, magnetic detector array, and method for their use in detecting biological molecules
EP1687634A4 (en) * 2003-11-12 2007-12-05 Univ Leland Stanford Junior Magnetic nanoparticles, magnetic detector arrays, and methods for their use in detecting biological molecules
WO2005073695A1 (en) * 2004-01-26 2005-08-11 Koninklijke Philips Electronics N.V. Method and device for on-chip magnetic resonance spectroscopy
CN100443914C (en) * 2004-02-20 2008-12-17 Tdk株式会社 Magnetic sensing device, method of forming the same, magnetic sensor, and ammeter
US7248045B2 (en) 2004-02-20 2007-07-24 Tdk Corporation Magnetic sensing device, method of forming the same, magnetic sensor, and ammeter
EP1566651A1 (en) * 2004-02-20 2005-08-24 TDK Corporation Magnetic sensing device, method of forming the same, magnetic sensor and ammeter
US8283183B2 (en) 2004-04-28 2012-10-09 Canon Kabushiki Kaisha Detecting method, detection device and detection kit
WO2005111615A1 (en) * 2004-05-17 2005-11-24 Randox Laboratories Limited Magnetic particle detector system
WO2005111614A1 (en) * 2004-05-17 2005-11-24 Randox Laboratories Limited Magnetic particle detector system and method of performing binding assay
WO2005111596A1 (en) * 2004-05-18 2005-11-24 Koninklijke Philips Electronics N.V. Magnetic rotation to improve signal-over-background in biosensing
JP2007538252A (en) * 2004-05-18 2007-12-27 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ Magnetic rotation to improve signal-to-background ratio in biological detection
US7892817B2 (en) 2004-05-18 2011-02-22 Koninklijke Philips Electronics, N.V. Magnetic rotation to improve signal-over-background in biosensing
JP2008500548A (en) * 2004-05-24 2008-01-10 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ Magnetoresistive sensor for high sensitivity depth probing
WO2005116661A1 (en) * 2004-05-24 2005-12-08 Koninklijke Philips Electronics N.V. Magneto-resistive sensor for high sensitivity depth probing
WO2006018811A1 (en) * 2004-08-20 2006-02-23 Instituto De Engenharia De Sistemas E Computadores Para Os Microsistemas E As Nanotecnologias (Inesc-Mn) A bio-electronic device
WO2006059270A2 (en) * 2004-11-30 2006-06-08 Koninklijke Philips Electronics N.V. Means and method for sensing a magnetic stray field in biosensors
JP2008522151A (en) * 2004-11-30 2008-06-26 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ Means and method for sensing stray magnetic fields in biosensors
WO2006059270A3 (en) * 2004-11-30 2006-08-31 Koninkl Philips Electronics Nv Means and method for sensing a magnetic stray field in biosensors
WO2006059268A2 (en) * 2004-11-30 2006-06-08 Koninklijke Philips Electronics N.V. A method for calibrating a transfer function of a magnetic sensor
US7508200B2 (en) 2004-11-30 2009-03-24 Koninklijke Philips Electronics N.V. Means and method for reducing magnetic cross-talk in biosensors
WO2006067646A3 (en) * 2004-11-30 2006-10-12 Koninkl Philips Electronics Nv Means and method for reducing magnetic cross-talk in biosensors
WO2006067646A2 (en) 2004-11-30 2006-06-29 Koninklijke Philips Electronics N.V. Means and method for reducing magnetic cross-talk in biosensors
WO2006059268A3 (en) * 2004-11-30 2006-10-12 Koninkl Philips Electronics Nv A method for calibrating a transfer function of a magnetic sensor
JP2006208295A (en) * 2005-01-31 2006-08-10 Canon Inc Magnetic sensor, detection method using it, target substance detecting sensor and target substance detecting kit
US8828740B2 (en) 2005-01-31 2014-09-09 Koninklijke Philips N.V. Rapid and sensitive biosensing
JP2008528998A (en) * 2005-01-31 2008-07-31 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ Fast and sensitive biosensing
US8486334B2 (en) 2005-01-31 2013-07-16 Canon Kabushiki Kaisha Magnetic sensor
WO2006080571A1 (en) * 2005-01-31 2006-08-03 Canon Kabushiki Kaisha Magnetic sensor
JP2006208296A (en) * 2005-01-31 2006-08-10 Canon Inc Magnetic sensor and detection kit
JP2006234762A (en) * 2005-02-28 2006-09-07 Asahi Kasei Corp Biosensor
CN100360939C (en) * 2005-05-26 2008-01-09 上海交通大学 Method for detecting cancer cell by using probe of piezoelectric sensing chip controlled from biologic magnetic
US7863022B2 (en) 2005-06-09 2011-01-04 Koninklijke Philips Electronics N.V. Amplification of nucleic acids with magnetic detection
WO2006131892A3 (en) * 2005-06-09 2007-02-22 Koninkl Philips Electronics Nv Amplification of nucleic acids with magnetic detection
WO2006134546A3 (en) * 2005-06-17 2007-03-08 Koninkl Philips Electronics Nv Accurate magnetic biosensor
WO2006134546A2 (en) * 2005-06-17 2006-12-21 Koninklijke Philips Electronics N.V. Accurate magnetic biosensor
WO2007010447A2 (en) * 2005-07-21 2007-01-25 Koninklijke Philips Electronics N. V. Microchip assembly with short-distance interaction
WO2007010447A3 (en) * 2005-07-21 2007-05-10 Koninkl Philips Electronics Nv Microchip assembly with short-distance interaction
US8283184B2 (en) * 2005-09-21 2012-10-09 Siemens Aktiengesellschaft Method for measurement of very small local magnetic fields, in particular for measurement of local magnetic stray fields produced by magnetic beads, and an associated device for carrying out the method
WO2007042959A3 (en) * 2005-10-12 2007-08-16 Koninkl Philips Electronics Nv Magnetic sensor device with different internal operating frequencies
WO2007042959A2 (en) * 2005-10-12 2007-04-19 Koninklijke Philips Electronics N.V. Magnetic sensor device with different internal operating frequencies
WO2007106580A2 (en) * 2006-03-15 2007-09-20 Micronics, Inc. Rapid magnetic flow assays
WO2007106580A3 (en) * 2006-03-15 2008-03-13 Micronics Inc Rapid magnetic flow assays
US8222023B2 (en) 2006-03-15 2012-07-17 Micronics, Inc. Integrated nucleic acid assays
US8772017B2 (en) 2006-03-15 2014-07-08 Micronics, Inc. Integrated nucleic acid assays
US8683877B2 (en) 2006-03-21 2014-04-01 Koninklijk Philips N.V. Microelectronic device with heating array
US8323570B2 (en) 2006-03-21 2012-12-04 Koninklijke Philips Electronics N.V. Microelectronic sensor device with sensor array
WO2007132372A1 (en) * 2006-05-09 2007-11-22 Koninklijke Philips Electronics N. V. A magnetic sensor device for and a method of sensing magnetic particles
WO2007132366A3 (en) * 2006-05-09 2008-03-27 Koninkl Philips Electronics Nv Microelectronic sensor device for concentration measurements
WO2007132384A3 (en) * 2006-05-09 2008-01-24 Koninkl Philips Electronics Nv Magnetic sensor device with field generators and sensors
WO2007132384A2 (en) 2006-05-09 2007-11-22 Koninklijke Philips Electronics N. V. Magnetic sensor device with field generators and sensors
WO2007129284A1 (en) 2006-05-10 2007-11-15 Koninklijke Philips Electronics N.V. System and methods for actuation on magnetoresistive sensors
WO2008091364A2 (en) * 2006-06-30 2008-07-31 Intel Corporation Nanoparticles as tags for bioanalyte detection by nuclear magnetic resonance or electron spin resonance
WO2008091364A3 (en) * 2006-06-30 2008-12-11 Intel Corp Nanoparticles as tags for bioanalyte detection by nuclear magnetic resonance or electron spin resonance
WO2008044162A3 (en) * 2006-10-09 2008-07-17 Koninkl Philips Electronics Nv Magnetic sensor device with pairs of detection units
CN101523215A (en) * 2006-10-12 2009-09-02 皇家飞利浦电子股份有限公司 Magnetic and/or electric label assisted detection system and method
US10151750B2 (en) 2006-10-12 2018-12-11 Koninklijke Philips N.V. Magnetic and/or electric label assisted detection system and method
CN101523215B (en) * 2006-10-12 2014-07-30 皇家飞利浦电子股份有限公司 Magnetic and/or electric label assisted detection system and method
WO2008044174A1 (en) 2006-10-12 2008-04-17 Koninklijke Philips Electronics N.V. Magnetic and/or electric label assisted detection system and method
US8936932B2 (en) 2006-10-12 2015-01-20 Koninklijke Philips N.V. Magnetic and/or electric label assisted detection system and method
WO2008102299A1 (en) * 2007-02-23 2008-08-28 Koninklijke Philips Electronics N.V. Magnetic sensor device with field generator and sensor element
US8283912B2 (en) 2007-04-03 2012-10-09 Koninklijke Philips Electronics N.V. Sensor device with magnetic washing means
EP2009456A3 (en) * 2007-06-29 2010-10-06 The Boeing Company Radio frequency sensor systems, electromagnetic sensor arrays, and methods of manufacture
WO2009034271A1 (en) * 2007-07-27 2009-03-19 Bertin Technologies Method for dosing an analyte in a liquid medium
FR2919390A1 (en) * 2007-07-27 2009-01-30 Bertin Technologies Soc Par Ac METHOD FOR ASSAYING AN ANALYTE IN A LIQUID MEDIUM
US8358123B2 (en) 2007-07-27 2013-01-22 Bertin Technologies Method of quantifying an analyte in a liquid medium having magnetic particles by application of a magnetic field to the liquid medium
US10809253B2 (en) 2007-09-20 2020-10-20 Magarray, Inc. Analyte detection with magnetic sensors
US9863939B2 (en) 2007-09-20 2018-01-09 Magarray, Inc. Analyte detection with magnetic sensors
WO2009063391A1 (en) * 2007-11-14 2009-05-22 Koninklijke Philips Electronics N.V. Means and methods for detection of nucleic acids
EP2060637A1 (en) * 2007-11-14 2009-05-20 Koninklijke Philips Electronics N.V. Means and methods for detection of nucleic acids
CN101952725A (en) * 2007-12-03 2011-01-19 国立大学法人东京工业大学 Biosensing method using coated magnetic microparticles and biosensing device to be used in the method
EP2246702A4 (en) * 2007-12-03 2011-09-28 Tokyo Inst Tech Biosensing method using coated magnetic microparticles and biosensing device to be used in the method
EP2246702A1 (en) * 2007-12-03 2010-11-03 Tokyo Institute of Technology Biosensing method using coated magnetic microparticles and biosensing device to be used in the method
WO2009081309A3 (en) * 2007-12-18 2009-08-20 Koninkl Philips Electronics Nv A magnetic sensor device
JP2009031303A (en) * 2008-09-22 2009-02-12 Canon Inc Detection device and kit for detection
US10794903B2 (en) 2008-10-17 2020-10-06 Minicare B.V. Pulsed magnetic actuation for sensitive assays
US9557328B2 (en) 2009-06-30 2017-01-31 Koninklijke Philips N.V. Magnetic sensor device, method of operating such a device and sample
WO2011001337A1 (en) * 2009-06-30 2011-01-06 Koninklijke Philips Electronics N. V. Magnetic sensor device, method of operating such a device and sample
US9272290B2 (en) 2009-07-17 2016-03-01 Koninklijke Philips N.V. Apparatus for the enrichment of magnetic particles
US9895692B2 (en) 2010-01-29 2018-02-20 Micronics, Inc. Sample-to-answer microfluidic cartridge
DE102010040391A1 (en) * 2010-09-08 2012-03-08 Siemens Aktiengesellschaft Magnetic flow cytometry for single cell detection
DE102010040391B4 (en) * 2010-09-08 2015-11-19 Siemens Aktiengesellschaft Magnetic flow cytometry for single cell detection
US9316575B2 (en) 2010-09-08 2016-04-19 Siemens Aktiengesellschaft Magnetic flow cytometry for individual cell detection
GB2497697B (en) * 2010-10-15 2020-01-15 Ibm Magnetic nanoparticle detection across a membrane
WO2012049075A1 (en) * 2010-10-15 2012-04-19 International Business Machines Corporation Magnetic nanoparticle detection across a membrane
US8815610B2 (en) 2010-10-15 2014-08-26 International Business Machines Corporation Magnetic nanoparticle detection across a membrane
CN103168239A (en) * 2010-10-15 2013-06-19 国际商业机器公司 Magnetic nanoparticle detection across a membrane
GB2497697A (en) * 2010-10-15 2013-06-19 Ibm Magnetic nanoparticle detection across a membrane
US9164100B2 (en) 2011-03-09 2015-10-20 Magarray, Inc. Systems and methods for high-throughput detection of an analyte in a sample
US9528995B2 (en) 2011-03-09 2016-12-27 Magarray, Inc. Systems and methods for high-throughput detection of an analyte in a sample
US9151763B2 (en) 2011-03-09 2015-10-06 Magarray, Inc. Systems and methods for high-throughput detection of an analyte in a sample
DE102011080945A1 (en) * 2011-08-15 2013-02-21 Siemens Aktiengesellschaft Dynamic state determination of analytes by means of magnetic flow measurement
US9927431B2 (en) 2011-09-14 2018-03-27 Regents Of The University Of Minnesota External field—free magnetic biosensor
WO2013059692A1 (en) * 2011-10-19 2013-04-25 Regents Of The University Of Minnesota Magnetic biomedical sensors and sensing system for high-throughput biomolecule testing
CN103987654A (en) * 2011-10-19 2014-08-13 明尼苏达大学董事会 Magnetic biomedical sensors and sensing system for high-throughput biomolecule testing
US9823316B2 (en) 2011-10-19 2017-11-21 Regents Of The University Of Minnesota Magnetic biomedical sensors and sensing system for high-throughput biomolecule testing
US10436713B2 (en) 2012-12-21 2019-10-08 Micronics, Inc. Portable fluorescence detection system and microassay cartridge
US11181105B2 (en) 2012-12-21 2021-11-23 Perkinelmer Health Sciences, Inc. Low elasticity films for microfluidic use
US10065186B2 (en) 2012-12-21 2018-09-04 Micronics, Inc. Fluidic circuits and related manufacturing methods
US10518262B2 (en) 2012-12-21 2019-12-31 Perkinelmer Health Sciences, Inc. Low elasticity films for microfluidic use
US10267871B2 (en) 2013-03-15 2019-04-23 Magarray, Inc. Magnetic tunnel junction sensors and methods for using the same
US10087440B2 (en) 2013-05-07 2018-10-02 Micronics, Inc. Device for preparation and analysis of nucleic acids
US10386377B2 (en) 2013-05-07 2019-08-20 Micronics, Inc. Microfluidic devices and methods for performing serum separation and blood cross-matching
US10190153B2 (en) 2013-05-07 2019-01-29 Micronics, Inc. Methods for preparation of nucleic acid-containing samples using clay minerals and alkaline solutions
US11016108B2 (en) 2013-05-07 2021-05-25 Perkinelmer Health Sciences, Inc. Microfluidic devices and methods for performing serum separation and blood cross-matching
EP3167300A4 (en) * 2014-07-09 2018-04-11 Zepto Life Technology, LLC Method and system for substance detection with a magnetic sensor
WO2018052639A1 (en) * 2016-09-15 2018-03-22 Qualcomm Incorporated Magnetoresistive (mr) sensors employing dual mr devices for differential mr sensing
US10060880B2 (en) 2016-09-15 2018-08-28 Qualcomm Incorporated Magnetoresistive (MR) sensors employing dual MR devices for differential MR sensing
WO2022269116A1 (en) * 2021-06-21 2022-12-29 Universidad Complutense De Madrid Sensor devices, electrical connection systems and methods for detecting genetic or biochemical material as disease biomarkers

Also Published As

Publication number Publication date
CN100343670C (en) 2007-10-17
KR20040068968A (en) 2004-08-02
ATE326697T1 (en) 2006-06-15
AU2002366904A1 (en) 2003-07-09
US20050087000A1 (en) 2005-04-28
EP1456658B1 (en) 2006-05-17
CN1608206A (en) 2005-04-20
US7048890B2 (en) 2006-05-23
DE60211555T2 (en) 2007-02-22
TW200411063A (en) 2004-07-01
JP2005513475A (en) 2005-05-12
DE60211555D1 (en) 2006-06-22
AU2002366904A8 (en) 2003-07-09
US20060128035A1 (en) 2006-06-15
EP1456658A2 (en) 2004-09-15
TWI295323B (en) 2008-04-01
WO2003054523A3 (en) 2004-03-18

Similar Documents

Publication Publication Date Title
EP1456658B1 (en) Sensor and method for measuring the areal density of magnetic nanoparticles on a micro-array
JP6043396B2 (en) Magnetic nanoparticles, magnetic detector arrays, and methods for their use in the detection of biological molecules
Graham et al. High sensitivity detection of molecular recognition using magnetically labelled biomolecules and magnetoresistive sensors
Li et al. Spin valve sensors for ultrasensitive detection of superparamagnetic nanoparticles for biological applications
US8486334B2 (en) Magnetic sensor
US7508200B2 (en) Means and method for reducing magnetic cross-talk in biosensors
US20060194327A1 (en) On-chip magnetic particle sensor with improved snr
US20090243594A1 (en) Method and device for characterization of a magnetic field applied to a magnetic sensor
US20100176807A1 (en) Magnetic sensor device
EP1299714A4 (en) High efficiency magnetic sensor for magnetic particles
US20100182002A1 (en) Magnetic sensor device with field generator and sensor element
Brückl et al. Magnetic particles as markers and carriers of biomolecules
Djamal Giant magnetoresistance material and its potential for biosensor applications

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2002790607

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 1320/CHENP/2004

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 10498958

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2003555187

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2002825869X

Country of ref document: CN

Ref document number: 1020047009884

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2002790607

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 2002790607

Country of ref document: EP